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In 1996 a large outbreak of Escherichia coli (E. coli) 0157 occurred in central
Scotland. The outbreak recorded the largest number of adults with HUS and
consequently the largest number of deaths, ever attributed to E. coli 0157. This
unfortunate event provided opportunity to investigate severe acute disease and the
chronic sequelae of infection. The retrospective studies aimed to assess host factors
associated with the development of the haemolytic uraemic syndrome (HUS), to
identify the earliest laboratory predictors of HUS, to develop a community
monitoring protocol able to detect those with early HUS, to define the role of
therapeutic plasma exchange (TPE) in the treatment of adults with HUS and to
determine genetically mediated inflammatory responses associated with the severity
of acute disease. The studies of chronic disease investigated renal function
abnormalities in cases surviving HUS, and gastrointestinal complications and quality
of life (QOL) in all cases. 512 cases were provisionally identified and 270 were
confirmed by stool culture. 120 cases were admitted to hospital, 34 developed HUS
and 17 died. Children and older adults were at greatest risk of HUS. However high
white cell count (WCC) at presentation was as least as good a predictor of HUS as
age. Acquired risk factors for HUS were low gastric acid and antibiotic therapy prior
to symptom onset. 186 patients were assessed for blood group markers (ABO, Lewis
and P). Blood group O and absent or weak expression of the PI erythrocyte antigen
were associated with HUS. Very high levels of TNFa, implicated in the pathogenesis
of HUS, were produced by leucocytes of P-negative individuals. Adults in
Lanarkshire who developed HUS were treated with TPE, which is unproven and
controversial in the context of E. coli 0157. The mortality associated with HUS was
45%, which compares favorably with previously reported mortality of 88%.
Therefore TPE appears to be a promising treatment. Thirty per cent of children
develop chronic renal disease following VTEC induced HUS but there was no
information on the renal outcome of adults. In Lanarkshire 12 of 22 adults with HUS
survived the acute illness. To the third anniversary chronic renal disease was
demonstrated in all; one progressed to ESRD, three developed CRF and eight had
clear evidence of renal insufficiency. Comparison with a control group confirmed
that these changes could not simply be attributed to age. Prospective investigation
determined the prevalence of irritable bowel syndrome (IBS) after E. coli 0157
infection and its impact QOL. On the second and third anniversaries of infection IBS
was significantly higher in cases compared to matched controls. Almost forty per
cent of cases developed new IBS within three years of infection. Cases with IBS had
significantly lower SF-36 scores in all scales particularly those reflecting mental
health. Therefore IBS is common after E. coli 0157 with a detrimental effect on
QOL. This thesis provides new insight into the pathogenesis and clinical
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In terms of recognition and impact on public health policy verocytotoxin producing
Escherichia coli (VTEC), and Escherichia coli 0157 (E. coli 0157) in particular, are
still emerging pathogens, causing concern because of the severity of their
complications. First recognised as a cause of haemorrhagic colitis in 1982 [Riley et
al., 1983], in subsequent years reported outbreaks continued to form a steeply
inclined epidemic curve. The factors underlying the emergence of VTEC are not
entirely clear. Increased incidence and recognition of infection are contributory,
certainly E. coli 0157 is not a new pathogen [Day et al., 1983], Recently the rise in
infection has perhaps been tempered and this is a tribute to the success of
improvements in surveillance, food handling, farm and slaughterhouse practices.
Scotland still has one of the highest rates of E. coli 0157 infection in the world,
although comparatively E. coli 0157 accounts for only a small proportion of all food
poisoning notifications (Figure 1.1). The morbidity associated with E. coli 0157
(31% of cases requiring hospital admission and an overall mortality rate of 3.7%)
greatly exceeds that seen in infectious intestinal disease caused by the other
pathogens (1.6% admissions and 0.1% mortality) [PHLS, 2000], The severity of
disease and well publicised incidents make E. coli 0157 the subject of intense
scientific research. Current interest is centred on the host susceptibility to severe
disease, clinical management of acute infection, chronic sequelae and at a molecular
level the mechanisms by which the verotoxins trigger the process that leads to the
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[Scottish Centre for Infection and Environmental Health, (SCIEH) 2002]
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1.2 Epidemiology of E. coli 0157 in Human Disease
1.2.1 History of infection
In 1982, an investigation by the Centres for Disease Control and Prevention (CDC)
of two outbreaks of severe bloody diarrhoea in the United States led to the
identification of a strain of E. coli, one that expressed O- antigen 157 and H-antigen
7 that had not previously been recognised as a pathogen [Riley et al., 1983], The
public health laboratories in the United States, the UK and Canada reviewed the
serotypes of the E. coli isolates that had been sent to them over the previous decade.
Since 1973, the CDC had serotyped over 3000 specimens of E. coli, only one of
these, a 1975 isolate from a Californian woman with grossly bloody diarrhoea, was
of serotype 0157:H7. The PHLS in the UK reported that it had found this serotype in
one of 15000 samples, Canada on the other hand found this serotype in six of 2000
isolates sent to them during the same years. Subsequent studies showed that sporadic
cases of the organism were widely distributed [Remis and Ruggenti, 1995, Pai et al.,
1984] and analysis of multilocus enzyme electrophoresis data has shown that the
evolution of E. coli 0157:H7 probably began on the order of 5 million years ago
[Whittam, 1995], Unfortunately it cannot be determined when this organism acquired
sufficient virulence to cause disease in humans, nor can one determine when it
emerged in animal populations.
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1.2.2 Reservoirs of infection
A bovine reservoir ofE. coli 0157 infection has been suspected since the first human
outbreak was linked with ground beef consumption. Prior to 1982, this serotype had
never been detected in veterinary samples. The organism has now been shown to be
present in the gastrointestinal tract of cattle where it is non-pathogenic. Estimates of
the prevalence of E. coli 0157 in North American and European cattle range from
less than 1% to almost 10% [Chapman et al., 1993], The organism has more recently
been detected in small numbers of sheep [Chapman et al., 1996] goats, horses, dogs,
geese, pigs and gulls, suggesting that its animal reservoir is extending. E. coli 0157
can survive for over 12 months in cattle faeces and over 20 weeks in soil samples
[Maule, 1999],
1.2.3 Vehicles of transmission
Beef [Mead and Griffin, 1988, Wall et al., 1996], particularly undercooked ground
beef, and dairy products [Djuretic et al., 1997] remain the most likely sources of
infection. The infective dose of E. coli 0157 is small and consequently cross
contamination is increasingly recognised as an important source of infection.
Cooked meats [SCIEH, 1997], radish shoots [Gutteriaz, 1997], potatoes, apple cider,
mayonnaise, lettuce and drinking water have all been implicated as vehicles in
outbreaks. Cross contamination by beef or contamination with bovine faecal material
has often been suspected as the route of transmission. Outbreaks involving acidic
foods, previously thought to be at low risk of transmission of pathogenic material,
have underscored the unusual acid tolerance of this organism. Direct or indirect
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contact with animals provides an alternative route by which infection is acquired
[Trevena, 1996], The median duration of shedding of the organism is 29 days [Shah
et al., 1996], it varies inversely with age and secondary attack rates of up to 22% are
reported in young children [Belongia et al., 1993], High rates of person to person
spread [Griffin and Tauxe, 1991] are important in causing outbreaks in schools, long
term care institutions, families and day-care facilities.
1.2.4 Patterns of infection
The livestock and beef industries changed dramatically during the past few decades
and changes in slaughterhouse practices and both commercial and domestic food
handling practices have all been implicated in the rise of infection. While no one
change can be singled out as a major contributing factor to the emergence of E. coli
0157, it is possible that these changes, have created a setting in which this organism
has been able to spread more readily into and through animal and human
populations. At the same time it is possible that the organism would have emerged as
a major pathogen regardless of these changes, based on its ability to move into
ecological niches in cattle and its virulence and low infectious dose in humans.
Because the diagnosis and reporting of E. coli 0157 has not been consistent over the
last decade, it is conceivable that the observed increase in incidence of infection was
artifactual. One direct gauge of the trend in infection is the incidence of HUS in
children, which because of the severity of the illness is less prone to ascertainment
bias. The number of HUS admissions in Scotland rose from 50 in 1980 to 250 in
1996, a rise paralleled by the number of E. coli 0157 isolates [Douglas and Kurein,
1997], which would suggest that the actual incidence of infection was indeed rising.
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There is a well-established seasonal trend in infection with a peak in summer each
year [Milford et al,. 1991], Most reported infection originally occurred in outbreaks
and there was evidence that sporadic infection was significantly under recognised
[Slutsker et al., 1998], The worst outbreaks were in Scotland (17 deaths) and in
Japan (10000 cases and 5 deaths) and both occurred in 1996. The 1995 Government
Advisory Committee on the Microbiological Safety of Food (ACMSF) and the 1997
Pennington report produced recommendations concerning methods of prevention of
E. coli 0157 transmission within foods and in the environment. These
recommendations may have been instrumental in the decline in infection (Figure
1.2). Since 1997 there have been between 20 and 30 small outbreaks per year in the
UK associated with unpasteurised milk, farms, cross contamination of cooked meats,
beefburgers, and faecally contaminated raw vegetables and water. With
implementation of the recommendation that laboratories test all diarrhoeal stools for
E. coli 0157 failure of recognition is less likely to remain a problem and 80% of
reported infection is now sporadic (Figure 1.3).
1.2.5 Geographical distribution of infection
E. coli 0157 has been isolated throughout the Western world particularly in Japan,
the UK, United States, Canada, Argentina and Australia. Geographical distribution
of infection in Scotland varies widely and incidence ranges from 0.9 to 15.1 per
100,000 [SCIEH 2002], The incidence of infection in England and Wales ranges
from 1.28-2.1 per 100,000 [Wilshaw, 2001], In the United States the overall
incidence is 1.65 per 100,000. Universally the incidence of infection is highest in
children under 5 years.
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Figure 1.2
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Figure 1.3












1.3.1 Classification of E. coli
E. coli, named after the German paediatrician Theodore Escherich who described it
in 1885, is the most common aerobe among the normal human colonic flora and is
also the most common human Gram-negative pathogen. E. coli belong to the family
Enterobacteriacea and thereby share the following properties: they are gram
negative rods, do not form spores, are motile by flagella or non motile, grow well on
MacConkey agar, grow aerobically and anaerobically, ferment D-glucose, are
catalase positive, reduce nitrate to nitrite, have 39 to 59 % guanine + cytosine content
of DNA. Five distinct groups of E. coli cause gastrointestinal illness. VTEC,
previously referred to as enterohaemorrhagic E. coli (EHEC), is the defined subset of
verotoxin producing E. coli. E. coli 0157.H7 and non 0157 verotoxin producing E.
coli belong to this group. Of the other four groups, enterotoxigenic E. coli (ETEC)
produces cholera-like enterotoxins that elicit profuse watery diarrhoea,
enteropathogenic E. coli (EPEC) causes infantile diarrhoea, enteroinvasive E. coli
(EEEC) invades intestinal epithelium and produces dysentery and enteroaggressive E.
coli (EaggEC) are more recently described, causing diarrhoea in children in the
developed and developing world.
Three antigenic groups serotype E. coli. the lipopolysaccharide O antigens, the
flagellar H antigens and the capsular K antigens. Approximately 170 O antigens and
60 H antigens are recognised. Following its ancestral divergence, E. coli 0157:1-17
lost its ability to ferment sorbitol and later its ability to produce p-D-glucuronidase.
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It acquired verotoxin 2 (VT2), then verotoxin 1 (VT1) and possibly other virulence
factors. The terminology used to describe the toxins produced by VTEC is confusing.
Initially described as verotoxins because of their cytotoxic effect on vero cell lines,
subsequently it was found that the toxin was immunologically, structurally and
genetically almost identical to Shiga toxin from Shigella dysenteriae and therefore it
was named Shiga toxin. Hence the terms verotoxin and Shiga toxin (Stx) are
interchangeable, as are the terms vero-cytotoxin producing E. coli (VTEC) and
shiga-toxin producing E. coli (STEC).
1.3,2 Pathogenesis
VTEC have three major pathogenicity mechanisms. They possess a plasmid-encoded
adherence protein mediating early mucosal interaction. This is followed by
attachment-effacement, identical to that of EPEC, mediated in part by intimin 0157,
an outer membrane protein [Louie et al., 1993], The intimin receptor has to be
translocated from the bacterium to the mucosal cell. The genetic information for this
process is housed on the genes for eae/Tir (enterocyte attachment and effacement
translocated intimin receptor) part of the locus of enterocyte effacement (LEE)
island. VT1 and VT2 are phage encoded enterotoxins and consist of an A and B
subunit. The B subunit binds to the glycolipid receptor globotriaosylceramide (Gb3)
permitting endocytosis of the complex (Figure 1.4). Gb3 is particularly rich in renal
glomeruli and the brain. After binding and internalisation of the toxin, the A subunit
is dissociated and transferred from the Golgi apparatus to the endoplasmic reticulum,
where it is cleaved into the k\ and A2 subunits.
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Figure 1.4 : Binding of B subunits of verotoxins to renal microvascular






















The toxic effect is mediated through the Ai subunit which inhibits protein
biosynthesis, by binding to the 60S ribosomal subunit, leading to apoptosis [Remuzzi
and Ruggenti, 1995], VT2 is 30 times more potent than VT1 [Nakao et al., 1999],
Bacterial derived lipopolysaccharides [LPS] can act synergistically with verotoxins
to initiate the inflammatory reaction in target organs by inducing the local production
of inflammatory mediators like tumour necrosis factor a (TNF-a) or interleukins. In
particular, enhanced TNF-a production might be pivotal in the pathogenesis of
vascular injury by favouring neutrophil adhesion, with subsequent release of
cytotoxic mediators, to the vascular wall [Lousi and Obrig, 1991],
Renal endothelial cell injury is probably the primary aetiological event in HUS.
Swelling of the endothelial cells, widened subendothelial regions and hypertrophied
mesangial cells combine to narrow the lumen of glomerular capillaries. Intraluminal
platelet thrombi with some fibrin polymers occlude the narrowed glomerular
capillaries and afferent arterioles [Habib, 1992]. In TTP arteriolar and capillary
microthrombi have been demonstrated in the brain.
1.4 Diagnosis of Infection
1.4.1 Faecal sampling
E. coli 0157 is the only serogroup of VTEC sought routinely by laboratories in the
UK. Strains of E. coli 0157:H7 are unable to ferment sorbitol rapidly and they are
detected on sorbitol MacConkey agar (SMAC) on which they grow as colourless
colonies. This has been used as a simple rapid means of screening stool specimens
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for E. coli 0157. Colourless colonies are confirmed as E. coli 0157 by antiserum
raised to the O-antigen. DNA probes have been prepared for both types of verotoxin
gene, VT1 and VT2, and can be used to detect verotoxin in faeces. The probability of
isolating E. coli 0157 and detecting the verotoxins in stool from patients is inversely
related to the interval between the onset of diarrhoea and microbiological culture
[Tarr, 1995]. Improved detection methods are therefore being developed.
Immunomagnetic separation (IMS) with anti-0157 beads is currently the most
efficient and practical for clinical use [Karch et al., 1996], It allows the detection of
7 7
small numbers of 0157 strains (10 CFU/g of stool in the presence of 10
background flora); it is 10-100 times more sensitive than direct culture and less
labour intensive than cytotoxic assay and PCR.
1.4,2 Serological diagnosis
In the past 10 years, the serological diagnosis of infection has been subject to much
investigation. There is as yet no universally agreed technique. The current UK
recommendation is that serum obtained one week after the onset of symptoms be
examined for antibodies to the 0157 lipopolysaccharide [LPS] antigen [PHLS,
2000], Demonstration of rising antibody titres with paired specimens or detection of
antibodies to 0157 LPS by immunoblotting, which detects predominantly IgM, is a
good indication of recent infection.
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1.5 Clinical Features of Infection
1.5.1 Symptoms
The clinical features of the acute disease have been documented by the description of
cases in outbreak situations. The incubation period for diarrhoeal illness is one to
eight days. The spectrum of disease is wide ranging from the asymptomatic infection
to death. Diarrhoea is the most common presenting symptom. Diarrhoea becomes
bloody in 50% of cases. Abdominal pain also is common and often severe. Fever and
vomiting are infrequent occurring in less than half of infected cases. The illness is
usually self limiting within seven days. In the UK about a third of diagnosed cases
are admitted to hospital [PHLS, 2000],
1.5.2 Complications
Gastrointestinal complications can be severe and ischaemic colitis, appendicitis,
oesophageal stricture, intussusception and large bowel perforation are all described.
Systemic complications were first recognised in 1985 when E. coli 0157 was
associated with the HUS [Karmali et al., 1985] and later TTP [MMWR 1986], HUS
is characterised by the triad of acute renal failure, thrombocytopaenia and
microangiopathic haemolytic anaemia. TTP was described when neurological
symptoms and signs predominated over renal impairment. Thrombotic
microangiopathy (TMA), the pathological basis of HUS, defines a lesion of small
vessel wall thickening, intraluminal platelet thrombosis and partial or complete
obstruction of the vessel. TMA presents as red cell haemolysis and
thrombocytopenia and is a precursor to HUS, but it can occur and resolve in the
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absence of overt clinical abnormality. The microvascular complications were shown
to be mediated by the E. coli 0157 toxins, VT1 and VT2 [Karmali and Tesh., 1991],
In recent years our understanding of the pathogenesis of HUS and TTP has evolved
and both are now regarded as the same pathological and clinical entity, generally
referred to as HUS [Todd, 2001],
Retrospective studies of outbreaks and sporadic cases have now shown that HUS
occurs in 2-15% of cases of gastrointestinal infection with E. coli 0157 [Griffin PM
and Tauxe, 1991], HUS develops almost exclusively in children and the elderly. The
usual renal presentation of HUS is with oligoanuria, proteinuria and microscopic
haematuria. The central nervous system (CNS) presentation of HUS ranges from
restlessness to coma. Seizures are not uncommon. Imaging may show cerebral
infarction or haemorrhage. Microvascular damage in the cerebral vessels,
hyponatraemia, thrombocytopaenia and hypertension all contribute to the CNS
presentation. Acute mortality in children has improved dramatically over the past
two decades and is reported between 5 and 10% in most centres. Reported mortality
in adults is much higher. The only significant adult cohort of E. coli 0157 associated
HUS, prior to the central Scotland outbreak, was from a Canadian nursing home
where the reported mortality rate was 88% in 12 cases [Carter et al., 1987],
1.5.3 Risk factors for systemic complications
The reason why HUS develops principally at the extremes of age is not clear but is
likely to lie in the mechanisms by which the verotoxins mediate the microvascular
thrombotic process. Verotoxin has been shown to bind to the glomeruli of infants
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and not to the glomeruli of adults but there is poor correlation between the peak ages
for HUS and the amount of Gb3 present in the kidney. Age related differences in
verotoxin absorption, glycolipid mediated verotoxin binding to Gb3 receptors and
rates of Gb3 synthesis at the time of illness are suggested explanations for the
discrepancy between verotoxin binding and Gb3 receptor concentration [Arbus,
1997], In E. coli 0157 infection, HUS develops two to 14 days after the onset of
diarrhoea. This provides a window of opportunity for laboratory monitoring and the
identification of risk factors for the development of HUS. In children neutrophilia
has been shown to be associated with progression to HUS. The value of other
laboratory and clinical risk factors has been evaluated without overall conclusion.
1,5,4 Clinical management of the acute illness
Management of gastrointestinal infection is essentially that of symptom control and
rehydration therapy with regular and careful monitoring for the development of
HUS. Observations from outbreaks, controlled clinical trials and in vitro studies have
failed to clarify the role of antibiotics in E. coli 0157 infection, and consequently,
the pattern of antibiotic use has changed little over the past 15 years. Particularly
there is concern that antibiotics may increase the risk of developing HUS.
Antimotility agents have been shown to be associated with HUS and should be
avoided [Cimolai et al., 1990, Akashi, 1994, Cohen, 1996],
A general consensus still credits the use of therapeutic plasma exchange (TPE) in
adults with idiopathic HUS and all patients with TTP [Ruggenenti et al., 1997],
where it has clearly been shown to reduce mortality and chronic renal disease
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[Conlon et al., 1995], In E. coli 0157 associated HUS, the role of TPE in children is
controversial and in adults there were no studies which reported its use. A prevailing
criticism of plasma exchange is that it is started when the criteria for HUS are met
and the microvascular process is already well established and perhaps beyond the
stage for optimal intervention. The identification of markers which precede the
development of HUS therefore has therapeutic implications.
1.6 The Host Susceptibility to Severe Disease
The wide spectrum of disease suggests that host factors are important in determining
disease outcome. There is increasing evidence for genetic influences in
proinflammatory responses such as TNFa and anti- inflammatory responses such as
interleukin 10 (IL-10) to bacterial antigens, particularly endotoxin [Westendorp et
al., 1997], Animal models indicate that endotoxin enhances the activity of verotoxins
produced by E. coli 0157. Inflammatory mediators markedly increase the binding of
verotoxin to endothelial cells and may thereby play an important role in the
pathogenesis of HUS. Individuals of blood group O have been shown to produce
higher levels of TNFa, IL6 and nitric oxide in response to Helicobacter pylori
[Alkout et al., 2000], It has been suggested that PI red blood cell phenotype [Taylor
et al., 1990] and blood type B [Shimazu et al., 2000] have a protective effect against
VTEC associated HUS. Verotoxins have been shown to bind to the erythrocyte PI
antigen. PI is a pentosyl ceramide that terminates, as does Gb3, in the galactose al-4
galactose disaccharide recognised by the B subunits of verotoxin (figure 1.4).
Whether or not PI expression or genetically mediated inflammatory responses,
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associated with blood group O, contribute to the severity of disease in patients with
VTEC infection has not been resolved.
1.7 The Chronic Sequelae of Infection
1.7.1 Chronic renal sequelae
The legacy of E. coli 0157 is now apparent. HUS is the commonest cause of chronic
renal failure in children and accounts for 2.7% of children undergoing renal
transplant in North America [Warady et al., 1997], Studies from children confirm
that a spectrum of renal complications occur, at least in this age group. The results of
the published reports on the late prognosis of HUS are difficult to compare for
various reasons, but overall, 70% of children recover normal renal function and 30%
have chronic renal abnormality of varying severity. There were no reports on the
renal outcome ofE. coli 0157 associated HUS in adults.
1.7.2 Chronic gastrointestinal sequelae
Symptoms secondary to bacterial gastroenteritis had traditionally been thought to be
brief and self-limiting, but there is now growing evidence for the legacy of
foodborne disease. Symptoms compatible with the irritable bowel syndrome (IBS)
have been shown to occur after gastrointestinal infection with salmonella,
Campylobacter and shigella. IBS affects sleep, employment, sexual functioning,
leisure, travel, diet and mood and consequently has a negative effect on quality of
life [Hahn et al., 1999], The extent to which IBS occurs after infection with E. coli
0157 was not known. Acute gastrointestinal symptoms and complications of E. coli
0157 are often severe suggesting potential for chronic gastrointestinal problems and
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late colonic stricture formation has been described [Griffin et al., 1990], Gall bladder
disease requiring cholecystectomy, chronic pancreatitis and insulin dependent
diabetes mellitus have all been described in a small number of children following E.
coli 0157 induced HUS.
1.8 The Central Scotland Outbreak
The central Scotland outbreak of E. coli 0157 was identified on the 22nd November
1996 and declared over on the 20th January 1997. In this period 512 cases were
identified and 279 confirmed by stool culture techniques. This remains the largest
outbreak of E. coli 0157 infection in the UK to date [Cowden et al., 2001], The
outbreak originated in a retail source in which cooked meats were cross
contaminated. The Lanarkshire town of Wishaw was at the centre of the outbreak,
but a second smaller outbreak was identified within the Forth Valley area. The first
identified cohort were guests and helpers who attended a Christmas lunch for elderly
parishioners on the 17th November 1996. Two other large cohorts within the
outbreak were, guests who attended an 18th birthday party in Wishaw on the 23rd of
November and residents and staff of a nursing home in Forth Valley who had eaten
various sandwiches over the weekend 23-24th November 1996. A significant
proportion of infected individuals were elderly, but ultimately the outbreak involved
people of all ages (Figure 1.5). An outbreak monitoring clinic was set up to monitor
cases in primary care.
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Figure 1.5
Age and sex distribution of confirmed E. coli 0157



















120 cases were admitted to three hospitals of these 34 developed HUS and 22 died
(17 deaths were considered to be directly attributable to E. coli infection at the Fatal
Accident Enquiry which followed the outbreak). The outbreak recorded the largest
number of adult cases developing HUS and ultimately the greatest number of deaths
attributed to E. coli 0157.
This unfortunate circumstance provided a unique opportunity to investigate adults
with uncomplicated gastrointestinal infection and HUS both during the acute illness
and in the longer term.
1.9 Aims and Objectives
In this thesis, clinical and laboratory data from the outbreak and follow-up study of
patients affected by E. coli 0157 during the 1996 central Scotland outbreak will be
presented and used to address the following questions.
1 What are the risk factors for HUS in adults infected with E. coli 0157?
2 What are the earliest laboratory predictors of the development of HUS?
3 During a large outbreak can a protocol be developed for monitoring patients
in the community that identifies those at risk of developing HUS?
4 Does therapeutic plasma exchange have a role in the treatment of adults who
develop HUS in the context ofE. coli 0157 infection?
5 Are genetically mediated inflammatory responses of individuals associated
with the severity of acute disease?
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6 What is the incidence of chronic renal function abnormalities in adults after
E. coli 0157 induced microvascular disease?
7 Do patients develop IBS or other gastrointestinal complications after E. coli
0157?
8 What is the impact ofE. coli 0157 infection on quality of life?
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CHAPTER 2
General Subjects and Methods
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2.1 Subjects
2.1.1 Retrospective study of outbreak
Subjects were cases identified during the 1996 Central Scotland outbreak of E. coli
0157. The case definitions employed during the outbreak and the number of cases
meeting each definition were as illustrated in Table 2.1. Subjects were eligible for
inclusion if they met the confirmed, probable, or possible case definitions. For the
community study confirmed, probable and possible cases were included. Confirmed
cases were those in whom the outbreak strain was isolated from stool following
standard culture on SMAC or after IMS. Provisional microbiological diagnosis was
made in the laboratories at Law Hospital, Monklands Hospital and Falkirk Royal
Infirmary. Isolates were confirmed and typed at the Scottish National Escherichia
coli Reference Laboratory. The outbreak strain was E. coli 0157 phage type (PT) 2,
VT type 2 positive. All isolates were subsequently shown to be indistinguishable by
pulsed field gel electrophoresis (PFGE). During retrospective analysis of the hospital
records it became apparent that serology correlated poorly with stool culture
confirmed infection, therefore serology was withdrawn from the case definition for
the hospital studies. Probable was redefined as bloody diarrhoea or HUS and an
association with implicated food source. Only confirmed and probable cases were
included in the hospital studies. There were 512 cases of which 279 were confirmed.
380 cases were from the Lanarkshire area, 127 from Forth Valley and, four from
Lothian and one from Greater Glasgow.
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Serology positive*** Serology negative**
Asymptomatic or no
history
Confirmed (35) Possible (53) Not a case
Non-bloody diarrhoea
only
Confirmed (77) Possible (54) Not a case
Bloody diarrhoea
and/or HUS
Confirmed (167) Probable (58) Possible (68)
*For the outbreak strain (E. coli 0157:H7, phage type 2, verocytotoxin type 2
producing, DNA profile by pulse field gel electrophoresis characteristic of the
outbreak strain) either by primary culture or immunomagnetic separation
**0r not done
***Or post mortem evidence of infection with the outbreak strain
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2.1.2 Prospective study of outbreak cases
For logistical reasons the prospective study was limited to cases from the
Lanarkshire area. Cases were those who had E. coli 0157 infection during the central
Scotland outbreak, who agreed on the first anniversary of infection to participate in a
follow-up study. For adult cases, age and sex matched adult controls were recruited
from the Community Flealth Index (CHI). CSC Scotland Healthcare Data Centre
extracted from the CHI database 10 possible control subjects, of the same sex and
year of birth, for each case. The permission of the individual's general practitioner
was sought to approach the control subject and invite them to participate.
2.2 Methods
2.2.1 Retrospective study of outbreak
All the data relating to cases identified during the outbreak were validated and linked
by the Information and Statistics Division (ISD) of the NHS in Scotland (Allan A,
1997). The data include patients' demographic features, microbiological,
biochemical, and haematological results. We developed a comprehensive clinical
database for all patients admitted to hospital. Data were collected from the hospital
case notes in Monklands Hospital and Law Hospital in Lanarkshire, and Falkirk
Royal Infirmary. Data were collected on premorbid illness, regular medications,
symptoms, signs, management and complications of the acute illness.
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2.2.2 Prospective study of outbreak cases
Cases and control subjects were reviewed annually by a research nurse, at
community clinics in Lanarkshire Health centres, to the third anniversary of
infection. Those unable to attend the clinic were visited at home. Annual review took
place in November and December of each year and ended in 1999. Assessment of
cases and controls ran simultaneously. All cases had a standard set of laboratory and
clinical investigations carried out. These same tests were carried out on controls.
Analysis of all serum and urine samples was carried out at Law Hospital
Laboratories in Lanarkshire.
Adult cases and controls were asked to complete a quality of life questionnaire (SF-
36) and an IBS questionnaire, both of which are self-completion questionnaires. A
research nurse obtained history of new events and medications. All results were
communicated to participants and their general practitioners.
2.2.3 The laboratory study
The laboratory study was carried out at the Infection and Immunity laboratory in the
Department of Microbiology at Edinburgh University. Blood for the laboratory
investigation was collected prospectively at the Lanarkshire clinics. For cases who
had died, blood groups were determined from the hospital notes.
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2.3 Definition of HUS
During the outbreak and throughout this study a consistent definition of HUS was
used. Patients were required to have all three of the following: red cell fragmentation
on blood film and lactate dehydrogenase >1.5 times the upper limit of normal;
thrombocytopenia (platelet count <150xl09/l); acute renal impairment (urea and
creatinine above the reference range and rising) and/or new neurological signs.
2.4 Statistical Analysis
Statistical analysis was carried out using SPSS (version 7.5 and version 9). Epi Info
was used for analysis of the laboratory study. CHI squared test and students t-test (2
tailed) were applied to examine statistical differences between groups. P <0.05 was
considered statistically significant and Odds Ratio (OR) >1 taken to equal
association. Assistance in multivariate statistical analysis was given by the Scottish
Centre for Infection and Environmental Health (SCIEH).
2.5 Ethical Approval
Subjects were provided with Information Sheets and they signed consent forms for




Monitoring Patients in the Community with Suspected
E. coli 0157 Infection During the Central Scotland Outbreak
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3.1 Introduction
Early in the course of the central Scotland outbreak the source of infection was
traced to a butcher's shop in Wishaw, a town with a population of approximately
50,000. The majority of cases lived in Wishaw and the surrounding area and
understandably there was a great deal of public anxiety about the outbreak within the
town. To ease resulting overwhelming pressure placed on local primary and
secondary care services a special community outbreak clime was quickly established
in the local health centre. The clinic aimed to support the public health investigation
into the outbreak, facilitate the provision of consistent public health advice to
minimise secondary spread of the infection, and co-ordinate the care of cases.
The outbreak clinic was principally used to monitor patients from the local
community with clinically suspected E. coli 0157 infection. A patient with onset of
diarrhoeal illness since the start of the outbreak was defined as having suspected
infection and these patients could be referred to the clinic by their General
Practitioners. In addition the clinic was also used by patients required to submit
samples for work exclusion purposes, and to follow up after discharge a number of
known cases who were admitted to hospital early in the course of the outbreak.
A protocol to guide the management of patients with suspected E. coli 0157
infection was drawn up at the start of the outbreak and was used consistently at the
clinic. The protocol specifically aimed to identify patients' case definition status,
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ensure early diagnosis of HUS, and facilitate prompt and appropriate referral of
patients requiring secondary care.
Stool microbiology and paired serology were performed to establish patients' case
definition status. Stool culture on SMAC was performed at the local laboratory,
however confirmatory tests were carried out at the Scottish E. coli 0157 reference
laboratory in Aberdeen. Due to the inevitable time delays involved in obtaining final
results from the reference laboratory, at the time patients were attending the clinic
their final case definition was often still unknown.
To monitor for HUS all patients with suspected infection had their haemoglobin,
white cell count (WCC), platelet count, blood film, lactate dehydrogenase level
(LDH), and serum urea and creatinine checked every two days for 14 days. Standard
criteria were developed to guide referral to secondary care. Referral was
recommended for patients with severe clinical manifestations of infection (such as
dehydration requiring parenteral fluid management) and patients whose laboratory
findings indicated the imminent development of HUS. A full account of the running
of the clinic including details of the management protocol used are given in the
Outbreak Report produced by Lanarkshire Health Board [LHB, 1999],
Previous studies have identified risk factors for HUS in patients with known E. coli
0157 infection. Young children and the elderly have consistently been found to be
more likely to develop HUS than young adults [Su and Brandt, 1995,Griffin and
Tauxe, 1991,Carter et al., 1987], Studies involving children have suggested that a
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raised WCC early in the course of illness is also associated with an increased risk of
HUS [Pavia et al., 1990, Bell et al., 1997, Akashi et al., 1994], Reports regarding
gender as a risk for HUS have been less consistent [Su and Brandt, 1995, Griffin and
Tauxe, 1991, Bell et al., 1997],
The database developed by ISD in Scotland provided the data for the study [Allan et
al., 1997]. Data examined included patients' demographic features, and all
microbiological, biochemical, and haematological results. The data provide a unique
opportunity to examine the features associated with the subsequent development of
HUS in patients from a wide age range with suspected E. coli 0157 infection.
In accordance with what is known about features associated with the development of
HUS in patients with known E. coli 0157 infection we have focused our analysis on
the ability of age and patients' WCC to predict the development of HUS in suspected
infection. The study of the community clinic did not examine other clinical features,
such as clinical features and antibiotic use, in detail. This is due to a lack of
information on such issues being recorded at the community clinic.
3.2 Subjects and Methods
Patients with suspected E. coli 0157 infection (but not in established HUS) who
were referred from primary care to the Wishaw clinic for monitoring were included
in the study.
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The case definitions employed during the outbreak and the number of cases meeting
each definition in the community clinic study were as illustrated in Table 3.1. In this
study a case was defined as any patient meeting the confirmed, probable, or possible
case definitions.
For the purposes of this study the outbreak definition of HUS was used. Patients
were required to have all three of the following:
• Red cell fragmentation on blood film, and lactate dehydrogenase >1.5 times the
upper limit of normal.
• Thromocytopenia (platelet count <150x109/l).
• Acute renal impairment and/or new neurological signs.
The day on which all three criteria were met are defined as the day of onset of HUS.
The socio-economic status of patients was assessed by converting postcodes of
residence into deprivation categories using the Carstairs and Morris index [Carstairs
and Morris, 1991], Deprivation categories are ranked 1 to 7, with 7 representing the
most deprivation.
We first assessed the association in patients with suspected infection between age,
and gender and subsequent development of HUS. We next mapped the clinical
course of the patients who developed HUS in detail to identify which laboratory
parameters became abnormal first. We then specifically assessed the ability of the
WCC to predict the development of HUS in patients with suspected E. coli 0157
infection.
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Serology positive*** Serology negative**
Asymptomatic or no
history
Confirmed (19) Possible (23) Not a case
Non-bloody diarrhoea
only
Confirmed (51) Possible (15) Not a case
Bloody diarrhoea
and/or HUS
Confirmed (72) Probable (28) Possible (37)
*For the outbreak strain (E. coli 0157:H7, phage type 2, verocytotoxin type 2
producing, DNA profile by pulse field gel electrophoresis characteristic of the
outbreak strain) either by primary culture or immunomagnetic separation
**Or not done
***Or post mortem evidence of infection with the outbreak strain
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The sensitivity, specificity, and predictive values of a patient being found to have
one or more abnormally high WCC results prior to the onset ofHUS were calculated.
An abnormally high result was defined as one above the age appropriate reference
range specified by the local laboratory (reference ranges for all laboratory parameters
are available on request). The exact method for calculating a confidence interval for
a single sample proportion was used to calculate 95% confidence intervals for all
results [Armitage and Berry, 1987], The analysis was repeated using neutrophil
count rather than total WCC. Finally we assessed the ability of age and WCC
considered together to identify patients at highest risk of developing HUS.
3.3 Results
3,3,1 Demographic data
In total 1,198 people presented to the Wishaw clinic. Of these 229 did not meet the
clinic's criteria for assessment, for example they had self referred, and hence were
given advice only. A further 36 people had no blood samples taken at the clinic, this
group includes people required to submit microbiological samples only for possible
work exclusion purposes. 933 people therefore underwent blood test monitoring
according to the clinic protocol. 39 of the 933 patients were referred from hospital
for post discharge follow up, for seven patients it was unknown whether they were
referred from primary or secondary care. The remainder were known to be referred
from primary care. One person referred from primary care was in established HUS
at the time of referral to the clinic so no information could be obtained on the
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features predating the development of their HUS. 886 patients were therefore
eligible for inclusion in the study (figure 3.1).
We consider this group to be representative of patients presenting to primary care
with suspected E. coli 0157 infection during a community based outbreak. Of the
886 patients monitored at the clinic, 245 were found to be cases. 170 cases (69%)
had confirmed or probable infection (table 3.1). 27 of the cases were admitted to
hospital, nine developed HUS, and two died.
The age and gender distribution of the patients monitored at the clinic is shown in
figure 3.2. A large proportion of cases monitored at the clinic were aged between 15
and 64 years and younger and older cases were under represented (figure 1.5). 89%
of the patients monitored at the clinic were resident in areas assigned deprivation
category five or six. This reflects the fact that Wishaw and its surroundings is a
relatively deprived area of Scotland.
3,3,2 Predictors ofHUS in all patients presenting
Men (3/346) and women (6/540) monitored at the clinic were equally likely to
develop HUS (Fisher's exact test p=1.0). Children <15 years and adults >64 years
(7/298) however were significantly more likely than adults aged 15-64 years (2/588)
to develop HUS (Fisher's exact test p=0.008).
37
Figure 3.1: Community clinic patients eligible for inclusion in the study
1,198 presented
I 229 advice only
969 formally assessed
I 36 no blood samples
933 blood test monitoring
4- 46 referred from hospital or referral source unknown
887 referred from primary care
I 1 in established HUS at time of referral
886 suitable for inclusion in the study
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Figure 3.2: The age and gender distribution of patients monitored at the
community clinic.
<1 14 5_14 15.34 35-64 65-74 >=75
Age gimp (yeais)
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In terms of assessing the ability of laboratory parameters to predict HUS, we initially
examined in detail the clinical course of the nine patients that developed
complications (table 3.2). The median interval between onset of symptoms and onset
of HUS was nine days (range 5 to 15). In general an elevated WCC preceded the
development of HUS and also preceded changes in urea, creatinine, LDH,
haemoglobin, and platelet levels, and the appearance of fragmented red cells (table
3.3).
Eight of the nine patients with HUS had a high WCC at some point during their
illness. In all eight the WCC became abnormal before the onset ofHUS, a median of
1.5 days after the onset of symptoms, and five days (range 1 to 8) before the onset of
HUS. In seven of the eight patients, the exception being the patient who did not
develop a raised WCC until 14 days after the onset of symptoms, the WCC was
abnormal on the first blood sample obtained when the patients presented.
Having confirmed that WCC was the first laboratory parameter to become abnormal
in patients developing HUS, we assessed the ability of a high WCC result to predict
subsequent HUS in the whole group of patients monitored at the community clinic.
The presence of one or more high WCC results predicted the subsequent
development of HUS with a sensitivity of 89%, specificity of 87%, positive
predictive value of 7%, and negative predictive value of over 99% (table 3.4).
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Table 3.3: Median interval between onset of symptoms and first abnormal result
in cases with HUS
Number of patients Median interval Range(days)
with an abnormal between onset of
result recorded at symptoms and first
some point during the recorded abnormal
course of their illness result (days)
wcc 8/9 1.5 0-14
Haemoglobin 8/9 7 1-12*
Fragmented red cells 9/9 7 3-15
LDH 9/9 4 1-10
Platelets 9/9 7 5-15
Urea 9/9 7 1-15
Creatinine 6/9 2 1-10
Day 0 is day of onset of symptoms
*Note that one of the 8 patients who developed anaemia only did so after the onset of
their HUS
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3.3.3 Predictors of HUS in cases
It is possible that diagnostic tests for E. coli 0157 infection, more rapid than current
stool culture techniques, may be developed in the future allowing primary care
practitioners to readily distinguish patients with definite infection from those with
other causes of gastrointestinal symptoms. For this reason we also assessed the
ability of a high WCC to predict the subsequent development of HUS in the cases
monitored at the clinic. The results were not significantly different to those for the
whole group of patients with suspected infection (table 3.4).
As it is specifically neutrophils that are implicated in the pathophysiology of
complicated E. coli 0157 infection, in addition we assessed the ability of the
neutrophil count to predict the development of HUS. We found that the neutrophil
count was not significantly better than the total WCC in predicting HUS.3.3.4 Predictive value of age and WCC combined
Finally, as we had identified age group and WCC as the features most strongly
associated with the subsequent development ofHUS in patients with suspected E.
coli 0157 infection, we assessed the predictive value of age group and WCC
combined. The positive predictive value of age (<15 or >64) alone was 7/298 (2.3%,
95% CI 0.9-4.8%); that of WCC alone was 8/121 (6.6%, 2.9-12.6%); and that of age
and WCC combined was 7/50 (14%, 5.8-26.7%).
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Table 3.4: The validity of a high white count result in predicting subsequent
development of HUS in all patients (cases) monitored at the community clinic
High white count HUS No HUS Total
Present 8(8) 113(49) 121 (57)
Absent 1 (1) 764(187) 765 (188)
Total 9(9) 877 (236) 886 (245)
Summary of results for all patients
Sensitivity 88.9% (51.8 - 99.7%)
Specificity 87.1% (84.9 - 89.3%)
Positive predictive value 6.6% (2.9 - 12.6%)
Negative predicative value 99.9% (99.3 - 100%)
Summary of results for cases
Sensitivity 88.9% (51.8- 99.7%)
Specificity 79.2% (74.1 - 84.4)
Positive predictive value 14.0% (6.3 - 25.8%)
Negative predicative value 99.5% (97.1 - 100%)
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3.4 Discussion
This study is unique in assessing features associated with the development of HUS in
a large number of patients, from a wide age range, with suspected E. coli 0157
infection monitored in a community setting during a large scale outbreak.
Children and the elderly with suspected infection are at higher risk of developing
HUS than young adults. This agrees with previous work involving patients with
known E. coli 0157 infection [Su and Brandt, 1995, Griffin and Tauxe, 1991, Carter
et al., 1987],
Significantly, this study also demonstrates the importance of a raised WCC as a
predictor of HUS, in patients of all ages with suspected as well as known E. coli
0157 infection. The study has shown that raised WCC is at least as good and
possibly an even better predictor of HUS than age and that patients with normal
WCC are at very low risk of HUS. Additionally it appears that WCC becomes
abnormal before the laboratory changes which characterise HUS.
During the central Scotland outbreak the Wishaw clinic was invaluable in alleviating
pressure on local services, and ensuring that patients received consistent information
and were monitored and referred on to secondary care in a consistent way. In
addition the clinic facilitated comprehensive data collection allowing subsequent
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evaluation to be undertaken. We would recommend the establishment of a similar
clinic during any large community based E. coli 0157 outbreak.
The protocol used at the clinic however required very comprehensive monitoring of
all patients with suspected infection, including patients that we could now identify as
being at very low risk of developing HUS. In the future a streamlined monitoring
protocol for patients in the community with suspected E. coli 0157 infection,
targeting those at extremes of age who present with high WCC, should be adopted.
46
CHAPTER 4
Risk factors for HUS and Death in all Cases Admitted to




In the community identification of risk factors for HUS in patients presenting with
suspected E. coli 0157 infection allows monitoring to be targeted at those with
greatest risk. In the hospital setting infection is largely already confirmed and the
emphasis is on the earliest identification of factors which predict progression from
gastrointestinal infection to HUS. This is especially true with the promise of new
agents that may block verotoxin absorption to prevent HUS [Armstrong et al, 1995,
Takeda et al., 1999], and the theoretical value of early TPE as possible treatment.
Extremes of age and raised WCC are the most consistently reported risk factors for
HUS [Drummond, 1985, Griffin et al., 1988, Carter et al., 1987, Pavia et al., 1990,
Walters et al., 1989, Milford et al., 1991, Kawamura et al., 1999], Both were
confirmed to be risk factors in the community study. There is disagreement regarding
antibiotic therapy anti-motility agents, fever, bloody stools, vomiting, and gender as
other potential risk factors in the progression to HUS [Carter et al., 1987, Pavia et
al., 1990, Butler et al., 1987, Cimolai et al., 1990, Bell et al., 1997, Proulx et al.,
1992, Takeda et al., 1998, Shiomi et al., 1999, Kimmit et al., 1999, Ikeda et al.,
1999, Wong et al., 2000], To date, most reports relate to the paediatric population
and features of adult disease are essentially unknown. Study of patients admitted to
hospital during the central Scotland outbreak allowed detailed investigation of HUS
in a predominantly adult group.
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4.2 Subjects and Methods
4.2.1 Data collection
Data were collected, from the case notes of all cases admitted to hospital, on
premorbid illness, regular medications, symptoms, signs, management and
complications. Clinical data were linked to demographic and laboratory data retained
on the ISD database.
4.2.2 Inclusion criteria
All "confirmed" and "probable" cases of E. coli 0157 infection admitted to hospital
during the central Scotland E. coli 0157 outbreak were included. "Confirmed" cases
were those in whom the outbreak strain was isolated from stool by standard culture
with or without IMS [Karch et al., 1996], "Probable" cases were those with bloody
diarrhoea or HUS and an association with implicated food sources, but no E. coli
0157 or other organism isolated. Retrospective analysis of serology performed
during the outbreak found it to correlate poorly with stool culture and clinical
diagnosis of infection, therefore to ensure that only true cases were included within
the hospital study, serology was withdrawn from the case definition and "possible"
cases were excluded.
4.2.3 Outcome measures
The definition of HUS was as in the outbreak and the community study. One patient,
who met all other criteria, was included as having developed HUS despite a
minimum platelet count of 228 (on death).
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4.2.4 Analysis
Demographic features, clinical symptoms and signs, antibiotic therapy, pre-morbid
illness, regular medication, pre-admission treatment and laboratory variables were
assessed in relation to outcome measures (HUS and death) using univariate and
multivariate logistic regression analysis. The dichotomization of continuous variables
was achieved based on either examination of their distribution, which yielded a
natural cut off, or from examples of categories used in previous studies. Due to
limited sample size, only variables found to be significantly associated with outcome
measures in the univariate analysis were included in the multiple regression model.
Symptoms and signs were taken as those recorded prior to, or within 24 hours of
admission. Fever was defined as axillary temperature > 37.5°C recorded within 24
hours of admission. Antibiotic therapy was included only if it was initiated within
four days of symptom onset. During the outbreak all cases admitted to one hospital
site were asked specifically about coincidental antibiotic use (prescribed for another
infection within four weeks prior to developing E. coli 0157 related symptoms) and
the use of antmotility drugs. This information was not recorded at other hospitals
and analysis is confined to patients who were admitted to the hospital where the data
were prospectively collected. Chronic pre-morbid illness and regular medication
were only assessed in adults (> 15 years of age), as no children had pre-morbid
illness or were taking regular medication.
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This outbreak was unique in that laboratory data were monitored in all possible cases
from presentation until day 14 of illness at least, in hospital or in the outbreak
monitoring clinic. WCC, neutrophil count, haemoglobin, albumin, LDH, urea and
creatinine were assessed as predictors of HUS in hospitalised cases using results at
first blood sample. Due to the potentially rapid development of HUS (3 days in one
case) only cases with a first blood sample within 48 hours of the onset of symptoms
were included. This restriction limited the sample size, therefore multivariate
analysis was not performed on this data. Further investigation of laboratory data (for
the first 14 days of illness), in all cases, was performed by examining the mean value
of variables per day after onset of symptoms, in the group who developed HUS and
those who did not. The t-test for equality of means was applied to detect the first day
in which there was a significant difference in each laboratory variable, between the
two groups.
4.3 Results
345 confirmed and probable cases of E. coli 0157 were identified in the Lanarkshire
and Falkirk areas. 279 (81%) cases were confirmed by stool culture techniques. 120
(35%) cases were admitted to three primary hospitals; two hospitals in Lanarkshire
and one in Falkirk. It is this group that was investigated in the regression analyses.
Age range of admitted cases was 18 months to 94 years, with a median age of 63
years. Admissions occurred between 20th November 1996 and 16th December 1996.
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4.3.1 Complications
HUS: 34 cases developed HUS, 26 adults and eight children. HUS developed a
median of 7 days (range 3-15 days) after the onset of gastrointestinal symptoms. 12
of 26 adults and 1 of eight children had neurological complications of HUS, the most
frequent of which was cerebrovascular accident.
Death: 16 (13%) hospital admissions died. All were aged over 65 years. 11 had
complete HUS, three had an incomplete form of HUS and two had no evidence of
microvascular complications. Seven of the 11 patients with HUS who died had
neurological complications. The mortality rate in adults with HUS was 42% (11 of
26).
4.3.2 Treatment
The mainstay of treatment was supportive with correction of fluid and electrolyte
imbalance. Antibiotic therapy for the treatment of gastroenteritis was prescribed
according to UK guidelines; therefore ciprofloxacin was given to cases aged over 60
years with pre-existing medical conditions or taking immunosuppressive therapy,
acid lowering drugs or ACE inhibitors [Farthing et al., 1996], 20 of 120 cases
received ciprofloxacin, no other antibiotic was given as primary treatment. TPE was
carried out in 16 adults in one Health Board area and one adult outwith this area.
Five adults so treated had progressive renal impairment requiring haemodialysis.
Seven children received dialysis.
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4.3.3 Predictors of HUS
Demographic details and clinical symptoms: Childhood and older age were
significantly associated with development of HUS (figure 4.1). 29 of 82 (35%) cases
aged <15 years or > 65 years developed HUS compared to 5 of 38 (13%) cases aged
15-65 inclusive (adjusted OR 4.4; 95% CI 1.3-14.4), (Table 4.1). Fever (adjusted
OR 2.7; 95% CI 1.0-7.6) and admission tachycardia, (> 100/min adults and >120/min
children), (adjusted OR 7.9; 95% CI 1.5-42.4) were associated with progression to
HUS. No other gastrointestinal or systemic features predicted development of HUS.
Premorbid medications and chronic illness: 9 of 15 (60%) adults with low gastric
acid (previous gastrectomy or taking proton pump inhibitors/ H2 receptor
antagonists) developed HUS (adjusted OR 6.7; 95% CI 1.9-24.0), (Table 4.2).
Antibiotics: 8 of 14 (57%) cases treated with any antibiotic in the four weeks prior to
the onset of E. coli 0157 related symptoms developed HUS (adjusted OR 4.7; 95%
CI 1.4-16.5), (Table 4.3). 7 of 15 (47%) cases treated with ciprofloxacin within 4
days of symptom onset and 26 of 104 (25%) cases who received no antibiotic
treatment developed HUS, but this difference did not reach significance, (OR 2.63;
CI 0.76-9.02), (Table 4.1).
Laboratory Investigations: In a univariate analysis, white blood cell count greater
than 20 x 109/1 (OR 8.3; 95% CI 1.1-60.3) and an absolute neutrophil count >15 x
109/1 (OR 8.5; 95% CI 1.5-50.1), within 48 hours of symptom onset, were both
significantly associated with the development of HUS. Serum albumin < 35g/l,
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Figure 4.1 Age distribution of cases admitted to hospital who developed
microvascular complications of E. coli 0157
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within 48 hours of symptom onset, was also associated with the development of HUS
(OR 7.2; 95% CI 1.2-42.5), (Table 4.4).
Sequential analysis of laboratory results for the first 14 days of illness on all 120
admissions included 901 samples, (Figure 4.2). This analysis confirmed that
neutrophilia and hypoalbuminaemia precede the laboratory changes regarded to be
indicative of the development of HUS. Significant differences in mean neutrophil
count, between those who developed HUS and those who did not, were present on
day two of their clinical illness. The traditional markers ofHUS development (LDH,
urea, creatinine and platelet count) became significantly different in the two groups
between day four and six of the onset of diarrhoeal symptoms. The sensitivity of a
neutrophil count >15 xlO9 /I as a predictor of HUS was 94% and the specificity 78%.
4,3.4 Predictors of death
All deaths occurred in patients over 65 years and so analysis in relation to this
outcome was confined to this age group. 11 of 16 (69%) of cases who died had HUS
and 3 of 16 had TMA. Dehydration and feeling light-headed on admission were the
only additional prognostic variables associated with death, (Table 4.1).
4.4 Discussion
This study of hospitalised cases comprised the largest number of adult cases of HUS
and deaths ever attributed to E. coli 0157. It confirmed age (< 15 or > 65 years) to
be an important predictor ofHUS development. Early neutrophilia also consistently
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Mean of laboratory results on each day of illness for cases who
developed HUS and those who did not









predicted the development of HUS and often preceded changes in other laboratory
markers by several days. This is in keeping with findings from the study in suspected
cases in the community and previous studies in children admitted to hospital. The
consistent association of neutrophilia with HUS reinforces speculation that
neutrophils are pivotal in the pathogenesis of endothelial injury, speculation which
has been validated by the recent discovery that neutrophils transport verotoxin in the
circulation [Monnens, 2000],
The finding that hypoalbuminaemia also preceded and predicted HUS is new. The
association of hypoalbuminaemia and HUS may be a manifestation of severe
gastrointestinal infection or capillary leak secondary to endothelial injury, but may
also reflect the fall in albumin seen in older people, in whom it is a well recognised
indicator of poor prognosis [Hodkinson, 1981],
Observations from the earliest outbreaks and a controlled clinical trial failed to
clarify the role of antibiotics in the development ofHUS [Carter et al., 1987, Pavia et
al., 1990, Cimolai et al., 1990, Bell et al., 1997, Proulx et al., 1992], Retrospective
analyses of the massive 1996 Sakai City outbreak in Japan contributed to this
conflict, children treated early with fosfomycin had reduced incidence of HUS
[Takeda et al., 1998, Shioi et al., 1999]. A prospective clinical trial in children in the
USA has demonstrated a clear association between sulpha containing and beta lactam
antibiotics and increased risk of HUS [Wong et al., 2000], In vitro evidence has
shown 4-quinolones to increase the release of verotoxin [Kimmitt et al., 1999] and
that this effect is mediated by phage replication [Zang et al., 2000], We were unable
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to demonstrate a significant association between early treatment with ciprofloxacin
and HUS, however only a small number of selected cases received early antibiotic
therapy. We did demonstrate an association between antibiotic use preceding E. coli
0157 related symptoms and the development of HUS. This association had not been
previously noted and may be a clinical manifestation of the effect of subtherapeutic
antibiotics. In vitro experiments have shown that subtherapeutic or inappropriate
antibiotics increase the release of verotoxin [Yoh et al., 1999], It now seems likely
that the effect of antibiotics on verotoxin production is dependant both on their
mechanism of action and achieving therapeutic concentrations. Our observations
with ciprofloxacin and coincidental antibiotics advocate against the use of antibiotic
therapy in E. coli 0157 infection.
The association of prior gastrectomy/acid lowering drugs with progression from
gastrointestinal infection with E. coli 0157 to HUS, has not been previously noted.
Patients have been shown to be at increased susceptibility to other types of bacterial
gastroenteritis after gastrectomy [Gianella et al., 1973], and one outbreak suggested
that previous gastrectomy was associated with acquiring E. coli 0157 infection
[Carter et al., 1987], E. coli 0157 is an acid tolerant organism and hypochlorhydria
was not thought to be relevant in its pathogenesis, however there is now evidence of
a wide range in acid tolerance among different isolates of E. coli 0157 [Brudzinski et
al., 1998], If the outbreak strain had reduced acid tolerance more severe illness
would be expected in cases with reduced gastric acid.
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Fever on admission was found to be associated with HUS in adults as it was in
children during the 1996 Japanese outbreak [Ikeda et al., 1999, Honda, 1999], Fever
therefore is likely to be a good surrogate marker for the severity of the inflammatory
response.
This detailed retrospective study of cases admitted to hospital investigated predictors
of HUS and death within an E. coli 0157 outbreak with predominantly adult cases
and a large number of deaths. The methods of the study ensure that no cases were
overlooked, that laboratory results and the collection of clinical data were both
accurate and complete. This was however a retrospective study and as such may be
limited by the accuracy and completeness of record keeping during the outbreak
period.
This study has shown that mortality associated with FIUS in adults remains high,
even with intensive management. We confirmed that age was the most important risk
factor for HUS and that neutrophilia as an early predictor extended to the adult
population. Additionally we identified low gastric acid and antibiotics prior to
acquiring infection as risk factors. The risk factors identified suggest avenues for
further research on the pathogenesis of HUS at a molecular level.
The community clinic and hospital studies provided complementary results. Both
have demonstrated risk factors for HUS, which can be defined and will facilitate the
management of outbreak situations and individuals in the future.
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CHAPTER 5
Effectiveness of Therapeutic Plasma Exchange in the 1996
Lanarkshire E. coli 0157 Outbreak
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5.1 Introduction
E. coli 0157 infection has the potential for serious and potentially life threatening
local [Griffin et al., 1990, Morris et al., 1991] and systemic complications [Karmali
et al., 1985, MMWR, 1986] of which HUS is the most severe. Acute renal failure is
integral to the systemic syndrome and studies from children with diarrhoea
associated HUS report that 70 percent require dialysis. The outcome in children has
improved significantly over the past two decades, largely due to improved dialysis
techniques and mortality rates between five and ten per cent are now the standard.
The neurological complications of HUS are responsible for much of this residual
mortality.
HUS is mediated by the E. coli 0157 verotoxins [Tesh and O'Brien, 1991],
Verotoxin is transported from the gastrointestinal tract to the sites of endothelial
damage by neutrophils [Monnens, 2000], Neutrophilia has been shown to predict the
development of HUS. The community and hospital studies of the central Scotland
outbreak have shown that neutrophilia generally precedes HUS by several days. The
first manifestation of the syndrome is TMA which is evidenced by red cell
haemolysis on laboratory tests. Therefore there is potentially a therapeutic window
for intervention prior to established end organ damage.
A general consensus still credits the use of therapeutic plasma exchange (TPE) in
adults with idiopathic HUS and in patients of all ages with TTP [Rock et al., 1991,
Ruggenenti et al., 1997], This is controversial in the context of E. coli 0157
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infection, as experience of TPE in the treatment of HUS induced by this organism is
limited. The first and largest cohort within the central Scotland outbreak was a group
of pensioners who attended a Christmas church lunch. Consequently a large
proportion of infected individuals were elderly. The elderly are known to be at
particular risk of developing HUS and the expected mortality rate in those treated
conservatively is reported at 88% [Carter et al., 1987], It was therefore decided early
in the course of the Lanarkshire outbreak to utilise TPE in the treatment of adults
who developed HUS.
5.2 Subjects and methods
5.2.1 Subjects
Clinical data, obtained by reviewing the case notes of all hospitalised cases in the
Lanarkshire area, was linked with laboratory and demographic data from the ISD
database. All "confirmed" or "probable" cases ofE. coli 0157 infection, identified in
the Lanarkshire area during the outbreak period, were included in the assessment and
analysis. Adults were defined as patients greater than or equal to 15 years of age.
5.2.2 Methods
This study applied the outbreak definition of HUS. All three criteria for HUS had to
be met prior to application of the diagnosis, but not necessarily on the same blood
sample. One patient was included as having developed HUS despite a minimum
platelet count of 228 (on death). He had bloody diarrhoea, an association with an
implicated food source, acute renal failure, the criteria for red cell haemolysis and a
falling platelet count.
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In the assessment of premorbid illness, past medical histories included as relevant
were ischaemic heart disease, cardiac failure, hypertension, cerebrovascular disease,
renal disease, diabetes and immunosuppression. Pulmonary oedema was diagnosed
on clinical and radiological evidence.
TPE was carried out at three centres using three Cobe Spectra Apheresis Systems and
a Baxter Fenwell CS-3000 Plus Cell Separator. Plasma was exchanged with 2-2.4
litres of fresh frozen plasma (FFP) or cryosupernatant (SNBTS) in refractory patients
[Rock et al., 1996]. The anticoagulant used was ACD-A. Vascular access was a
combination of central and peripheral venous access. Intravenous hydrocortisone was
given with each exchange. Intravenous prostacyclin was also given to cases receiving
TPE, at doses between 40mg and 200mg/hr, where tolerated.
5.2.3 Statistical Analysis
Data was analysed using SPSS version 7.5.
5.3 Results
5,3.1 Patient demographics
There were 262 cases of E. coli 0157 infection in the Lanarkshire area: 200
confirmed and 62 probable cases. The median age of all affected was 53 years
however cases polarised at the extremes of age (Figure 5.1). 47% (124/262) of
infected individuals were over 55 years of age. Thirteen (5%) cases died. In 10 cases
death was associated with the systemic complications of E. coli 0157 infection.
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Figure 5.1





5.3.2 Systemic complications ofE coli 0157
Twenty-eight (11%) of the Lanarkshire cases of E. coli 0157 satisfied the diagnostic
criteria for HUS. Cases satisfied the criteria for HUS a median of 7 days (range 4 to
15 days) after the onset of gastrointestinal symptoms. A further eight cases had
evidence of thrombotic microangiopathy but did not satisfy the criteria for HUS and
were not eligible for TPE. Twenty-two (79%) cases with HUS were adults and six
(21%) were children. The median age of adults who developed HUS was 71 years
and the median age of children 6 years. The demographics, clinical features,
treatment, laboratory results and outcome of the adult cases with HUS are shown in
Table 5.1. Blood results are taken from the day that the diagnostic criteria for HUS
were met, prior to TPE in cases so treated.
The mortality rate in adults with HUS was 45% (10 of 22). Mortality was 58% (7 of
12) in those aged over 70 years and 30% (3 of 10) in those aged 70 years or less.
There were no deaths in children. All cases who died had a post mortem carried out.
Causes of death in patients with HUS were acute renal failure secondary to HUS (2
cases), cardiac arrest (2 cases), intracerebral haemorrhage, cerebral infarction, acute
myocardial infarction, multiple organ failure, hepatorenal syndrome secondary to
macronodular cirrhosis and septic shock.
5.3.3 TPE
TPE was carried out on 16 of the 22 adult patients with HUS. Four patients treated
with TPE went on to receive haemodialysis in addition, because of deteriorating
renal function. Patients who did not receive TPE were either too unwell to tolerate
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the procedure or died before TPE could be carried out. The reasons for not
performing TPE are detailed in Table 5.2.
In all 16 cases treated with TPE, the first exchange was first carried out within 24
hours of the criteria for HUS being met. The minimum number of exchanges carried
out was one, the maximum 16 and the median six. Patients underwent a total of 107
procedures and 1100 units of FFP were used. Two patients proved refractory to
treatment with FFP, after five and six exchanges, but were successfully treated with
additional TPE using cryosupernatant as the exchange fluid.
In the TPE treated group the mortality rate was 31%, with 50% (4 of 8) mortality in
those aged over 70 years and 12.5% (1 of 8) mortality in those aged less than 70
years or less. Premorbid illness, neurological features, treatment with ciprofloxacin
or prostacyclin and the laboratory severity of E1US were not associated with death,
however the number of cases were too small to allow statistical conclusion.
5.3.4 Complications of TPE
The most frequent complication associated with plasma exchange was pulmonary
oedema. This was diagnosed on clinical and radiological grounds in 11 (69%) cases.
Pulmonary oedema was not confined to patients undergoing TPE and occurred in
50% (3 of 6) of HUS cases not treated with TPE. Hypocalcaemia (calcium <2.12
mmol/1) occurred in 15 of 16 patients treated with TPE. Although often severe
(minimum serum calcium 1.32 mmol/1) intravenous calcium supplements were given
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6 69 M Cardiac arrest prior to transfer for plasma exchange
8 70 M Diagnosis not suspected
13 71 F Cardiac arrest prior to transfer for plasma exchange
17 76 M Fluid overload, pneumonia, septicaemia
19 79 F Acute abdomen, dementia, relatives wish
22 90 F Fluid overload, precarious fluid balance
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Hypomagnesaemia (magnesium <0.7 mmol/1) occurred with in 8 patients,
intravenous magnesium was given as appropriate and no clinical effects were
observed. Other complications associated with TPE were MRSA line infection and
extravasation.
5.4 Discussion
Until recently HUS was a rare disease in adults with an estimated frequency of one
case per million per year [Petit, 1980], In 50% of cases it was associated with
pregnancy, malignant hypertension, HIV, autoimmune disease, cancer or
chemotherapy. The remainder of cases were familial or of unknown aetiology. In
1983 the first association of HUS with E. coli 0157 infection was made [Karmali,
1985] and the incidence of the disorder has since continued to rise in parallel with the
global rise in E. coli 0157 infections [Armstrong el al., 1996], Following exposure to
E. coli 0157, between three and seven per cent of all patients progress to overt HUS
[Mead et al., 1988], but incident rates are much higher in children and the elderly.
HUS has quite a different course and prognosis in adults compared to children.
Children with HUS develop acute renal failure precipitately and the treatment of
choice is dialysis, which is initiated when the child becomes oliguric. Most children
respond to dialysis and this is evidenced by falling morbidity and death rates [Begue
et al., 1998], In the central Scotland outbreak there were no deaths in children.
Adults have a different manifestation of disease and appear to develop neurological
or cardiovascular problems before the onset of oliguria. Neurological features have
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previously been shown to be associated with increased mortality [Hughes et al.,
1991] and neurological and cardiovascular complications of HUS were the most
frequent causes of death in the Central Scotland outbreak.
There has been no previously reported experience of the use of TPE in the treatment
of adults with HUS caused by E. coli 0157 infection. The only other reported
experience ofE. coli 0157 induced HUS in adults, was from a Canadian nursing
home outbreak in 1985. In that outbreak 11 of 12 patients who developed HUS died,
compared with 10 of the 22 in the central Scotland outbreak. The patients who
developed HUS in the nursing home outbreak were slightly older (mean age 83
years) and probably frailer than our patients. All patients from the nursing home
outbreak were admitted to hospital and treated with full supportive therapy but
without TPE. We believe that our use of TPE was the only treatment difference
between our patients and those reported from the Canadian nursing home outbreak.
Also in our patients we can find no evidence of any other treatment influencing
outcome from HUS. We therefore suggest that without the use of TPE the proportion
of HUS cases who died would have been higher.
When HUS develops secondary to gastrointestinal infection with E. coli 0157
endothelial damage is mediated by the lysogenic-phage encoded verotoxin 1 and 2
[McBrien et al., 1983, Tesh and O'Brien, 1991], The verotoxins enter the systemic
circulation causing microvascular damage at target organs by a process that is
thought to be mediated by pro-inflammatory cytokines such as TNF-a and
interleukins [Lousi and Obrig, 1991], Endothelial damage induces the formation of
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large von Willebrand factor multimers [Moake and McPherson, 1989], which in turn
may cause platelet aggregation with the formation of small vessel thrombi in target
organs. These combined processes are manifest clinically as thrombocytopenia,
hemolytic anaemia, renal impairment and neurological problems such as confusion,
seizures and cerebrovascular accidents. The theoretical basis for use of TPE in E. coli
0157 infection is that it may remove verotoxins, pro-inflammatory cytokines and
von Willebrand factor multimers from the circulation, thereby removing the factors
which initiate and perpetuate the microvascular process that leads to HUS.
Plasma exchange is an expensive (£2500 per person treated in our hospital) and
intensive procedure. Also it is not without risk and most reported complications
relate to the need for central venous catheterisation. The effectiveness of TPE in the
treatment of E. coli 0157 induced HUS needs to be determined definitively. This
would best be achieved by a multicentre randomised-controlled trial. When faced
with a disease with a very high mortality and only one potentially beneficial
treatment option a trial that withholds this option would be difficult to justify. In the
context of sporadic and outbreak cases ofE. coli 0157 it would also be extremely
difficult to organise logistically. There will always be an unavoidable selection bias
within such a trial, with patients who are excluded from treatment because they have
contraindications to TPE or who die before treatment can be initiated.
Assuming five per cent of all cases of E. coli 0157 develop HUS approximately 40
adult cases of HUS per year would be expected in the UK (data from PHLS
Communicable Disease Surveillance Centre and SCIEH). A national register should
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be established for adult cases of HUS, as was recently operative for paediatric cases.
This database would enable monitoring of treatment and outcomes in adults,
providing definitive evidence of the effectiveness of TPE within about 5 years.
In the interim, we have reported our use of TPE in the treatment of the largest
number of adult cases of HUS secondary to E. coli 0157. We have recorded an
overall mortality rate of 45%, compared with a historical mortality rate of 88%. We
believe this provides evidence for the effectiveness of TPE in the treatment of adults
with HUS caused by E. coli 0157. There is no evidence from our experience that
TPE is harmful. A national register of HUS secondary to E. coli 0157 could define
the role of TPE in the treatment of this serious condition.
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CHAPTER 6




Morbidity and mortality associated with the 1996 outbreak of E. coli 0157 in
central Scotland raises the question of why some individuals exposed to this
organism developed severe disease and others did not. Aside from the extremes of
age, few demographic factors have been associated with susceptibility to this
disease. Studies of other enteric pathogens indicate blood group is a risk factor for
some of these diseases. Occurrence or severity of diarrhoeal disease due to E. coli
[Black et al., 1987], Vibrio cholerae and Helicobacter pylori are associated with
two genetic characteristics: the O blood group; and the inability of individuals to
secrete the water-soluble glycoprotein forms of their respective ABO blood group
antigens (non-secretion) [Swerdlow et al., 1994, Alkout et al., 1997, Chaudhuri
and Das Adhikary, 1978], The P blood group is a receptor on endothelial surfaces
for the verotoxin [Bitzan M et al., 1994], but there have been conflicting reports
on association between P blood group and susceptibility to disease due to E. coli
0157 in Caucasian populations [Taylor et al., 1990, Robson et al., 1994, Ashida
et al., 1999].
Previous work demonstrated that H. pylori bound in higher numbers to cells of
individuals of blood group O and binding of the bacteria was significantly
associated with expression of H type 2, the antigen of blood group O [Alkout et
al., 1997], In addition, individuals of group O produced significantly higher levels
of tumor necrosis factor a (TNF) and interleukin 6 (IL-6) in response to H. pylori
[Alkout et al., 2000],
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The aims of the study were:
1) to assess ABO, P blood groups and secretor status among patients with disease
due to E. coli 0157 in comparison with the population in central Scotland.
2) to determine if the H type 2 antigen is a receptor for the outbreak strain or
other strains of E. coli 0157.
3) to assess inflammatory responses to a culture filtrate of the outbreak strain in
relation to ABO and P blood groups.
6.2 Subjects and Methods
6,2.1 Subjects
There were 186 patients in the study who developed disease due to confirmed E.
coli 0157 infection during the Lanarkshire outbreak. For each case ten possible
age and sex matched control subjects were generated from the Lanarkshire CHI by
computer selection and with their general practitioners consent they were invited
to participate, 122 agreed and are included as control subjects. Blood was taken
from cases at the time of infection and from cases and control subjects annually to
the third anniversary of infection. Information on ABO but not Lewis or P blood
groups was available for 16 individuals who died in Lanarkshire hospitals, 12
from Monklands District General Hospital in Airdrie and 4 from Law Hospital in
Carluke. Results for patients and CHI controls were also compared with figures
obtained for previous studies in central Scotland [Blackwell et al., 1990, Peebles
Brown et al., 1994],
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Patients with clear evidence of red cell haemolysis were regarded as having VT-
mediated TMA, a proportion of which progressed to HUS. HUS was defined by
the original outbreak criteria.
6.2.2 Determination of blood groups
ABO group was determined by slide agglutination with monoclonal anti-A and
anti-B reagents from the Scottish National Blood Transfusion Service (SNBTS).
Lewis antigens were determined by tube agglutination with monoclonal anti-
Lewis3 and anti-Lewisb (SNBTS). Polyclonal anti-P typing serum (SNBTS) was
used in slide agglutinations and results recorded as 3 = strong, 2 = moderate, 1 =
weak and 0 = no visible agglutination. The cells were also incubated with the
anti-P serum for 30 min at room temperature and agglutination assessed by flow
cytometry in comparison with cells incubated for 30 min with phosphate buffered
saline (PBS). Secretor status was assessed by haemagglutination inhibition tests
and results compared with results for Lewis3 and Lewisb antigens by ELISA for
Lewis antigens in saliva.
6.2.3 Bacteria
In addition to the outbreak strain, eight additional strains of E. coli 0157 of
different phage types were obtained from Dr. M.F. Hanson, Central
Microbiological Laboratory, Western General Hospital, Edinburgh. The bacteria
were cultured in category 3 containment facilities and formalin fixed cultures used
in the binding assays.
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6.2.4 Bacterial binding to epithelial cells
The flow cytometry method described previously was used for assessment of
bacterial binding to buccal epithelial cells of the different ABO blood groups and
the Kato III gastric epithelial cell line [Alkout et al., 1997], Blood group antigens
were detected with monoclonal antibodies to H type 2, A, B, Lewis3 and Lewisb
by flow cytometry. Bacterial binding was examined in relation to level of
expression of blood group antigens reflected in the level of monoclonal antibodies
bound [Alkout et al., 1997],
6.2.5 Screening for bacterial adhesins that bind blood group antigens
The spectrophotometric methods for detection of direct binding of biotinylated
synthetic blood group oligosaccharides (Syntesome) was used [Alkout et al.,
1997], Binding of fluorescein-labelled blood group oligosaccharides (Syntesome)
to the bacteria was also examined by flow cytometry. The strain of H. pylori
NCTC 11637 [Alkout et al., 1997] which expresses fucose-binding adhesins was
included in each experiment as a positive control.
6.2.6 Inflammatory responses to E. coli 0157 antigens
Inflammatory responses elicited from leukocytes by a sterile culture filtrate of E.
coli 0157 were assessed by blood group and P antigen level of the donor. The
bacteria were grown in nutrient broth for 24 h at 37°C in universal containers. The
bacteria and filtrates were prepared in a category III containment facility. Buffy
coats from blood donors (n = 32) were obtained from the Blood Transfusion
Service, Royal Infirmary of Edinburgh. There were 8 sets of A, B, O and AB
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donors and the levels of IL-6 and TNF were assessed by ELISA and bioassay
respectively [Gordon et al., 1999],
6,2,7 Statistical analyses
Samples were coded so that the blood groups were determined without reference
to patient or control group. Results were entered into a database and assessed by
the Epi Info package. Prevalence was compared between groups by chi-squared




ABO and P blood groups were determined for 186 patients from the Lanarkshire
outbreak and 122 controls obtained form the CEH list. Because the proportion of
group O among the 122 CHI group was higher than that for the population
covered by the Lanarkshire Blood Transfusion Service based at Law Hospital
(51%, personal communication Dr. K. Liddle), data for ABO groups were also
compared with those from our previous study on an outbreak of meningococcal
disease at the Airdrie Academy [Blackwell et al., 1990] and data for blood donors
in greater Glasgow [Peebles Brown et al., 1994]
There was no significant difference between the proportion of group O between
patients (63.4%) and the CHI group (58.3%); however compared with the larger
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groups, Airdrie (n = 371) (53.4%, P < 0.05) and Glasgow (n = 5898) (53.9%, P <
0.01), there was a significant increase in group O among the patients. The
proportion of patients with HUS who were group O was 18/28 (64.3%); however,
among patients who died 14/16 (87.5%) were group O, and this was significantly
increased compared to all three control groups (P < 0.05) (Figure 6.1). There
were no differences in the proportions of secretors and non- secretors of ABO
blood group antigens observed between patient and control groups.
Red blood cells from 83 of 135 patients (61.5%) who attended follow up clinics
were not agglutinated or only weakly agglutinated by the anti-P antiserum
compared with 46 of 113 (40.7%) of the samples from the CHI controls ( P =
0.0017, CI 1.35,4.00). Among 17 patients who developed TMA and who attended
the follow up clinics, 14 (82.4%) had no or weak reactions with anti-P compared
with the CHI controls (P = 0.0032, CI 1.73-38.41). Among patients with TMA, 12
developed HUS and 10 (83.3%) had no or weak reactions with anti-P compared
with the CHI controls (P = 0.0130, CI 1.43,70.37). Data on P blood group were
not available for patients who died.
6,3,2 Bacterial binding in relation to blood group and secretor status
Nine strains ofE. coli 0157, including the outbreak strain, were tested for binding
to epithelial cells of secretor and non-secretor donors of blood groups A, B, O and
AB. There was no correlation between binding of the bacteria to the Kato III cell


















































6.3.3 Binding of labelled blood group oligosaccharides to E. coli O 157
None of the strains bound any of the biotinylated or fluorescein-labelled ABO or
Lewis blood group antigens although the oligosaccharides bound to the H. pylori
control in the assays.
6.3.4 Inflammatory responses and blood group
There were no significant differences in levels of either TNF or IL-6 associated
with ABO group. With respect to P antigen on the red cells, there were no
differences in IL-6 levels. There were 8 donors whose red cells were not
agglutinated by anti-P, and of these, 5 produced TNF levels > 100 IU ml"1 in
response to the culture filtrate. None of the samples from donors expressing P
antigen on their red cells produced TNF responses approaching 100 IU ml"1 (P=
0.001).
6.4 Discussion
Among patients affected during the Lanarkshire outbreak of E. coli 0157, the
proportion of group O was 63.4% which was significantly higher than the general
populations in the surrounding area (51-53.3%) but not significantly increased
compared with the internal control group of 122 individuals extracted from the
CHI. The proportion of O individuals who died during the outbreak was
significantly increased compared with all three control groups. In contrast to
previous studies on H. pylori [Alkout et al., 1997, Alkout el al., 2000], increased
susceptibility of group O to disease due to E. coli 0157 was not associated with
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increased binding of bacteria to epithelial cells of group O or to higher
inflammatory responses of group O leukocytes.
The high proportion of patients with disease due to E. coli 0157 (61.5%),
particularly those who developed TMA (82.4%) or HUS (83.3%), whose
erythrocytes were not agglutinated or weakly agglutinated by anti-P antiserum
supported the findings obtained for 32 children with HUS. Among these children
there was a significant excess of patients with weak of absent expression of PI,
particularly among those with poor outcome [Taylor et al., 1990], Unfortunately
there was no information on the P blood group for patients who died. Two
possibilities are suggested: 1) the P antigen on erythrocytes can absorb the VT and
prevent it reaching target cells in the kidney or brain; 2) VT and/or endotoxin in
the culture filtrate is better able to bind to leukocytes of individuals who do not
express P or have low levels of this antigen on their cells.
TNF has been implicated as a major factor in tissue damage in an animal model of
E. coli 0157 [Isogal et al., 1998], High levels of TNF, IL-6, interleukin-8,
interleukin 10 and interleukin 1 receptor antagonist (IL-IRa) have been reported
among patients infected with E. coli 0157 [Proulx et al., 1998], The induction of
very high levels of TNF by the culture filtrate from leukocytes of P-negative
individuals is an observation to be pursued. The results of these studies
complement findings of an increased proportion of individuals with low levels of
P antigen on their red cells in the patient group, particularly among the patients
who developed HUS. This observation might help identity individuals at greater
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risk of more serious disease caused by E. coli 0157, in particular those who would
benefit from TPE.
This study identified two genetic risk factors for disease due to E. coli 0157.
Although the original hypothesis that individuals of group O might be at increased
risk of disease was supported by the data, the variations in levels of the P blood
group antigen appear to be more important in relation to severity of disease.
These findings provide new avenues to investigate the differences in host
susceptibility factors and responses that contribute to development of serious
kidney and vascular damage in response to these infections.
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CHAPTER 7




In the two decades since the systemic complications of E. coli 0157 were recognised
[Karmali et al., 1983], acute mortality in children has improved dramatically and is
reported at less than 10% in most centers. Approximately 50% of children with HUS
require dialysis [Mead and Griffin, 1988] and improved outcome reflects advances in
dialysis techniques. Reported mortality in adults remains much higher. The only two
significant adult cohorts of E. coli 0157 associated HUS are from a Canadian
nursing home where the reported mortality rate was 88% in 12 cases [Carter et al.,
1987] and from our experience in Central Scotland where the mortality was 42% in
26 cases. It is not clear if the excess residual mortality in adults is a manifestation of
advanced age or if it reflects more severe microvascular disease.
The pathological basis ofHUS is small vessel wall thickening, intraluminal platelet
thrombosis and partial or complete obstruction of the vessel. Global
glomerulosclerosis, tubular atrophy and interstitial scarring have been demonstrated
in renal biopsies in the convalescent and chronic phase [Moghal et al., 1998],
Therefore the potential for chronic renal disease is evident and the legacy ofE. coli
0157 is becoming apparent. HUS is now the commonest cause of chronic renal
failure in children and accounts for 2.7% of children undergoing renal transplant in
North America [Warady et al., 1997], End Stage Renal Failure (ESRF) is the
extremity of a spectrum of chronic renal abnormality induced by HUS. The range of
renal disease has been extensively investigated in children (Table 7.1, Figure 7.1).
The results of published reports when taken as a whole suggest, of the patients who
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survive the acute illness, 73% recover normal renal function, 12% have minor
abnormalities of renal function of uncertain significance at the time of reporting,
12% have significant abnormality of renal function and 3% develop ESRF.
In adults HUS develops almost exclusively in patients over 60 years of age. The
reason for this predilection is not known but it does not appear to reflect premorbid
illness. The assessment of impaired renal function in adults after HUS is complicated
by the decline in renal function with age (GFR is maintained at approximately
140ml/min/1.73 m2 until the age of 30, thereafter it declines by about
8ml/min/1.73m2 per decade. [Rowe et al., 1976]), comorbidity and concomitant
medications, each of which may have an effect on renal function. The large number
of adult HUS cases in the central Scotland outbreak of E. coli 0157 provided
opportunity to investigate the chronic renal sequelae of HUS in adults. To address
the complexity of assessment of renal function in older age the study included a
control group.
7.2 Subjects and methods
7.2.1 Aims
The primary aim was to determine the prevalence of renal disease after HUS, in
adults to the third anniversary of infection with E. coli 0157. A secondary aim was
to compare the prevalence of chronic renal disease in adults with published reports
94
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Figure 7.1 Published studies reporting outcomes from HUS in children
Renal Outcomes in Children
10 11 12
Studies
□ Group 1: normal □ Group 2: minor abnormality □ Group 3: renal impairment □ Group 4:ESRD
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in children. The final aim was to investigate abnormality of renal function in cases
with no obvious microvascular complication during the acute illness.
7.2.2 Subjects
Subjects were cases from Lanarkshire infected with E. coli 0157 during the 1996
central Scotland outbreak, who agreed on the first anniversary of infection to
participate in the project. The cases were split into two groups, adults and children (<
15 years). The two groups were further subdivided into cases who had HUS or TMA
and cases with uncomplicated gastrointestinal infection. HUS and TMA were defined
from the outbreak presentation.
Data analysis on the first anniversary highlighted a wide variation in creatinine
clearance (Ccr) measurement without substantiating evidence of renal function
abnormality. Therefore on the second and third anniversaries of infection, for adult
cases age and sex matched control subjects were sought from the CHI. Ten control
subjects for each case were invited to take part.
7.2.3 Methods
Baseline information, from the medical records, was obtained for all cases on
premorbid illness, medication and the clinical history of acute infection with E. coli
0157.
Cases were reviewed at a community clinic annually to the third anniversary;
controls were reviewed on the second and third anniversaries. At annual review
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participants had blood was taken for measurement of creatinine, submitted a 24hr
urine collection for Ccr measurement and timed albumin measurement and an Early
Morning Urine (EMU) specimen for microalbumin measurement. Explanation and
written instructions were given on the procedure for urine collection. Weight and
blood pressure (systolic blood pressure (SBP) and diastolic blood pressure (DBP))
were recorded by standardised method. In children height was measured. New events
and medications were documented.
The design was a case observational study for children and adults to the first
anniversary and a case control study for adults on the second and third anniversaries.
Ccr and blood pressure (BP) in adult cases with HUS were compared with
measurements in all control subjects. All adult cases with uncomplicated
gastrointestinal infection were compared with a single age and sex matched control.
Renal abnormalities persisting in children after the incident were determined and any
found were assumed attributable to the E. coli 0157 infection. Annual review of all
participants took place between November and December 1998 and 1999. Ethical
approval was granted by Lanarkshire Health Board Research Ethics Committee.
7.2.4 Outcome measures
Four evolution patterns were defined at the end of follow-up:
> Group 1. Complete recovery; (Ccr>80ml/min/ 1.73 m2, normal BP and no
proteinuria).
> Group 2. Minor abnormaility; (Ccr>80ml/min/ 1.73m2, protein in EMU or 24hr collection
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>20 and <250mmol/l, hypertension SBP>160mmHg or DBP>90mmHg).
> Group 3. Renal insufficiency; (Ccr 50-80ml/min/ 1.73m2 with or without
proteinuria > 20mmol/l or hypertension)
> Group 4: Chronic renal failure (Ccr 10-49ml/min/1.73m2 with/without
proteinuria or hypertension).
> Group 5. End stage renal failure (ESRF); (Ccr<10ml/min/1.73 m2 with/without
proteinuria or hypertension).
7.2.5 Statistical Analysis
Data was analysed using SPSS version 9. Statistical differences were examined by
chi-squared test and two-sample Student's test. P<0.05 was considered to be
statistically significant and 0R>1 taken to indicate association.
7.3 Results
166 (141 adults) cases infected with E. coli 0157 attended on the first anniversary of
infection. 138 (120 adults) cases attended on the second anniversary, and 116 (105
adults) on the third anniversary. 133 control subjects were recruited from the CHI of
which 110 attended on the third anniversary.
During the outbreak 28 cases developed HUS and nine TMA. 12 of the 37 cases with
a microvascular complication died during the acute illness and one case died 4
months afterwards (Figure 7.2). Of the 24 surviving cases, 15 were adults and nine
children. All 15 adults and 4 of 9 children are included in the study (Table 7.2).
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Three adults and one child were treated with dialysis, and 11 adults were treated with
TPE during the acute illness. Five children who are reviewed annually by the
paediatric nephrologists, declined to participate and details of their renal function
was obtained from their physician.
7,3,1 Outcome in adults
In 12 adults who had HUS, 1 progressed to ESRD, 3 developed CRF, 8 had clear
evidence of renal insufficiency, and none had normal renal function. Of the 3 adults
with TMA, one had CRF on a background of pre-existing essential hypertension, and
two normal renal function (Table 7.2).
To determine if the measured renal abnormalities in adults could be attributed to
HUS or simply reflect age and the limitations of 24 hr urine collection as an estimate
of glomerular filtration, all Ccr measurements in HUS cases were compared with all
measurements in control subjects. To allow equivalence for age only controls greater
than 62 years of age were included in the analysis. There were 33 Ccr measurements
in HUS cases and 126 in control subjects over 62 years of age. The mean age of both
groups was 71 years. The median Ccr after HUS was 49 umol/1 compared to 76
umol/1 in controls. There was a significant difference between the mean Ccr after
HUS (49umol/l) compared to controls (76umol/l) (p<0.001). Ccr <80ml/min/1.73m2
occurred in 31/33 (94%) HUS measurements and 79/126 (63%) control
measurements, p<0.001, OR 9.2 (2.1-40.3). Ccr <25 ml/min/1.73m2 occurred in
6/33 (18%) HUS and 3/126 (2%) control measurements, p=0.003, OR 9.1 (2.1-38.7).
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More than half of people aged over 60 years have a BP over 160/90mmHg, therefore
blood pressure measurements in cases with HUS was also compared with controls.
There were 32 BP measurements in cases with HUS and 127 BP measurements in
controls aged more than 62 years. 17 (53%) of cases and 35(28%) controls had SBP
over 159mmHg [(p=0.01) OR 3.0(1.3-6.6)]. 15 (47%) cases and 32 (25%) controls
had DBP over 89mmHg, [p=0.029, OR 2.6 (1.2-5.8)].
On the third anniversary, 84 cases with uncomplicated gastrointestinal infection with
E. coli 0157 were matched for age and sex with one control subject. 61 of 84 were
female and 23 male, the sex distribution reflecting the female preponderance in
outbreak cases. The mean age of uncomplicated cases and matched controls was 58
years. The mean urinary Ccr in cases was 93 ml/min compared with 91 ml/min in
controls (n.s.). 9(11%) cases and 7(9%) controls had a creatinine clearance < 80
ml/min/1.73m2 (n.s.). 3(4%) cases and no controls had creatinine clearance <
25mls/min/1.73m . Five (6%) cases and five controls had increased urinary protein
on 24-hr collection and EMU (>20mg/l). There were no differences in means or
extremes of systolic or diastolic blood pressure between the two groups.
7,3,2 Outcome in children
Of 3 children who had HUS two had renal insufficiency and one minor abnormality
at the end of the study period. One child with TMA had normal renal function. Of the
five children attending the paediatric nephrologists, all were known to have normal
renal function at the end of the study period.
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13 children who had uncomplicated gastrointestinal infection participated in the
study. One child had persistent microalbuminuria with albumin ranging from 26-62
mmol/1 on five samples. Urinary tract infection was excluded and no reason for
micralbuminuria was identified. Otherwise children who did not have HUS appeared
to have normal renal function. There was a wide variation in Ccr measurements
without supportive abnormality of renal function, which is likely to reflect
difficulties in specimen collection in this age group.
7.4 Discussion
In the developed world E. coli 0157 induced HUS is now established as the
commonest cause ofchronic renal failure in childhood. Over the past three decades,
the spectrum of renal abnormality seen after HUS has been investigated in children.
The results of published studies are difficult to compare and make inference from.
These difficulties arise because the studies originate from different geographical
areas with different epidemiological backgrounds, cover different time periods,
report different proportions of diarrhoea associated HUS, extend to different periods
of follow up and report different methods and definitions in the assessment of
outcome of renal function (Table 7.1). Reduced GFR, increased urinary protein,
significant microalbuminuria, hypertension, reduced renal functional reserve, chronic
renal failure and ESRF have all been reported in varying proportions. The first
reported experience of HUS was from Argentina [Gianantonio et al., 1973], 124
cases presenting between 1957-1972 were reviewed between five to thirteen years
after presentation. 48% showed recovery, 18.5% had deterioration in renal function
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of which almost half had progressed to ESRD, in the remainder there was minor
abnormality. The proportion of these cases caused by E. coli 0157 or other VTEC is
a matter for speculation. Retrospective surveys of E. coli 0157 isolates serotyped by
public health laboratories in the UK, USA and Canada show that serotype 0157:H7
was rare in diarrhoeal specimens during the 1970s. [Griffin and Tauxe, 1991], More
recent studies include a significant proportion of patients who have diarrhoea
associated HUS (D+HUS). A recent study from the UK presented outcome of 114
patients with D+HUS [Small et al., 1999], 1 patient had ESRF, 5% had moderate
CRF (Ccr 25-50 ml/min/1.73 m2), 22 % mild CRF (Ccr 50-80 ml/min/1.73 m2) and
72% normal renal function. Accumulation of all significant studies in the past three
decades has shown mortality during the acute phase of 6% (range 2-17%). Of the
patients who survive the acute illness, 73% (range 38-100%) recover normal renal
function, 12% (1-31%) have minor abnormalities of renal function of uncertain
significance at the time of reporting, 12% (2-28%) have significant abnormality of
renal function and 3% progress to ESRF (1-16%), Table 7.1.
Follow-up data has largely focused on patients who have received dialysis. The
development of chronic renal failure correlates with the number of days of dialysis
and the duration of oligoanuria during the acute illness [Hughes et al., 1991, Seigler
et al., 1991], However there have been reports of progressive renal disease in
patients who did not receive dialysis [Small et al., 1999] had no apparent oligoanuria
[Seigler et al., 1991] and with apparently minor HUS [Gianantonio et al., 1973],
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The published rate of complication in children is the benchmark for expected
outcome in adults. The numbers in our study are small but this is the only significant
cohort of adults with E. coli 0157 associated HUS. Of the 12 adults who survived
HUS none had normal renal function, 1 had ESRD, one quarter had CRF the
remainder and showed clear evidence of renal insufficiency. Comparison with the
control group has shown significant differences between cases with HUS and
controls in both Ccr and BP confirming that the measured abnormalities are not
simply a reflection of the decline of renal function with age.
Eleven adults in this study were treated with TPE. It has been suggested in adults
with HUS not related to E. coli 0157 that TPE may limit the number of patients with
chronic renal sequelae [Conlon et al., 1995], Our experience of TPE in adults with E.
coli 0157 associated HUS suggested that it influenced the course of HUS and
improved prognosis during the acute illness. The small numbers involved make it
impossible to assess the impact of this intervention in the late outcome of renal
function in the cases presented.
Cases with TMA had no significant abnormality of renal function. Adult cases with
uncomplicated gastrointestinal infection had the same prevalence of renal function
abnormalities as the control population. There is therefore no suggestion that cases
other than those who have had HUS require renal follow-up.
There has been uncertainty as to the optimal duration of follow-up of children with
HUS. There is evidence that patients with normal GFR 2 years after HUS [De Jong
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and Monnens, 1988] and normal protein/creatinine ratio in EMU at five years will
with high probability keep normal renal function [Milford et al., 1991], Others
however have shown a late deterioration of renal function after apparent recovery,
and recommend follow-up examinations for at least 10 years [Tonshoff et al., 1994,
Siegler et al., 1991], The high prevalence of renal function abnormality in our
patients suggests that all adults should be followed up after E. coli 0157 associated
HUS. The optimal duration of follow up remains uncertain. The risk of progression
to ESRD is likely to be multifactorial and cumulative, influenced by the severity of
the acute renal insult, age and comorbidity.
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CHAPTER 8
Prevalence of the Irritable Bowel Syndrome and its Impact on




Symptoms secondary to bacterial gastroenteritis were traditionally thought to be brief
and self-limiting, but there is now growing evidence for the legacy of foodborne
disease. Symptoms compatible with the irritable bowel syndrome (IBS) have been
shown to occur after gastrointestinal infection with salmonella, Campylobacter and
shigella [McKendrick and Read, 1994, Neal et al., 1997, Rodriguez and Ruigomez,
1999], The largest study to date reported the prevalence of IBS to be 7%, six months
after infection with Campylobacter, salmonella or shigella [Neal et al., 1997]. The
only study to include a control group reported a prevalence of IBS of 4% at 1 year;
the relative risk of IBS for cases was 10 times that of the control population
[Rodriguez and Ruigomez, 1999],
Female sex [McKendrick and Read, 1994], the duration of diarrhoea during the acute
illness [Neal et al., 1997] and psychological factors [Gwee et al., 1996] have been
suggested as risk factors for the development of post infective IBS. Patients have
been shown to have less psychiatric morbidity than those with idiopathic IBS and are
thought to have a better overall prognosis [Chaudhary and Truelove, 1962, Harvey et
al., 1987], IBS affects sleep, employment, sexual functioning, leisure, travel, diet and
mood [Hahn et al., 1999], Recent publications have quantified the detrimental effect
of idiopathic IBS on quality of life (QOL) [Gralnek et al., 2000, Creed et al., 2001],
The extent to which IBS occur after infection with E. coli 0157 is not known. Acute
gastrointestinal symptoms and complications of E. coli 0157 are often severe.
Haemorrhagic colitis occurs in 70% of cases and ischaemic colitis [Griffin et al.,
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1990], appendicitis, oesophageal stricture and large bowel perforation are recognised
complications of the acute illness [Morris et al., 1991], The severity of the acute
illness suggests potential for chronic gastrointestinal problems and late colonic
stricture formation has been described [Griffin et al., 1990], The study assessed the
prevalence of gastrointestinal symptoms and IBS, annually to the third anniversary of
infection, in patients who had E. coli 0157 during the 1996 central Scotland
outbreak. Gender and the severity of the acute illness were examined as risk factors
for the development of IBS. Finally the impact of IBS on patients QOL was assessed.
8.2 Subjects and methods
8,2,1 Subjects
Subjects were patients infected with E. coli 0157 in Lanarkshire during the 1996
central Scotland outbreak. Patients were invited for clinical review annually to the
third anniversary of infection. At first review cases over 5 years of age were asked to
complete a questionnaire with respect to their bowel habit before the E. coli 0157
infection and their current bowel habit (Figure 8.1). The questionnaire was a self-
completion questionnaire adapted from that validated by Neal et al [Neal et al.,
1997] in their assessment of IBS after bacterial gastroenteritis. Analysis of this data
highlighted recall bias and reporting of bowel symptoms in children as possible
sources of error. Therefore on the second and third anniversaries of infection analysis
is confined to adult cases (15 years or older), for whom control subjects were sought.
For each case ten possible age and sex matched control subjects, were generated
from the CHI. Ultimately one matched control subject, with no history of
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gastroenteritis, was recruited for each case. Control subjects completed the
questionnaire on the second and third annual review.
8.2.2 Methods of diagnosis
A diagnosis of IBS was made from the questionnaire using modified ROME criteria
[Thomson et al., 1989] (Figure 8.2). In keeping with accepted criticisms of the
ROME criteria [Camilleri, 1998] and the variable nature of IBS, subjects had
difficulty specifying symptom frequency. A minimum symptom frequency was not
therefore included within the definition of IBS. The history of cases acute symptoms
was obtained from hospital notes, general practice records and by interview. In
addition subjects completed a QOL questionnaire, SF-36 UK version, on the second
and third anniversaries. The questionnaire was scored according to Medical
Outcomes Trust guidelines [Ware, 1997],
One study reported pancreatitis in 23% of patients with E. coli 0157 [Fukushima et
al., 1999], Abdominal pain is integral to the definition of IBS and therefore it is
possible that chronic pancreatic disease could have been mistaken for IBS. To
exclude pancreatic disease, serum amylase and glucose was measured at review.
8.2.3 Statistics
Chi-squared test, Fishers exact test, Odds Ratios with 95% Confidence Intervals and





149 (67%) of the 224 Lanarkshire E. coli 0157 cases, aged over 5 years, attended for
clinical review on the first anniversary of infection and completed the bowel
questionnaire. Cases included in the study were older than those who declined to take
part, but there were no differences in severity of acute gastrointestinal symptoms
between the those who participated and those who did not (Table 8.1).
8.3.2 Prevalence of IBS
On the first anniversary of infection the median age of cases was 58 years, 10 cases
were aged between 5 and 15 years. 104 of 149 (70%) were female. The most
frequently reported bowel symptoms were variation in bowel habit and abdominal
pain, however all gastrointestinal symptoms were increased in prevalence compared
to before infection. Before E. coli 0157 infection 9 of 149 (14%) cases satisfied the
ROME criteria for IBS. One year after infection 44 of 147 (29%) satisfied the
modified ROME criteria, OR [3.4 (CI 1.8-55)], (Table 8.2). Within 1 year of
infection 34 (23%) cases had developed new IBS, (Table 8.3).
On the second anniversary 103 of the 108 adult cases completing the questionnaire
could be matched for age and sex with a control subject. The median age was 60
years. 38 of 103 (37%) cases and 11 of 103 (11%) controls satisfied the ROME
criteria for IBS, [OR 4.89 (CI 2.3-10.3)], Table 8.2.
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Figure 8.1: Bowel Questionnaire
Please complete questionnaire on your current bowel habit
Yes How many No
days a week
1. Do you suffer from abdominal pain? □ => □ □
2. Do you pass loose or watery stools (motions)? 0 => □ □
3. Does your bowel habit vary from day to day? □ => □ □
4. Do you have to strain to open your bowels? □ => □ □
5. Do you rush to the toilet to open your bowels? □ => □ □
6. After opening your bowels do you ever feel the need to go to the toilet again? □ => □ □
7. Do you pass slime or mucous when opening your bowels? □ :=> □ □
8. Do you feel bloated or that your abdomen is swollen after eating a meal? □ => □ □
9. Do you have to loosen your clothing after eating a meal? □ => □ □
Figure 8.2: Modified ROME criteria for irritable bowel syndrome
Modified Rome criteria
Abdominal pain +
Irregular pattern of defecation (three or more of the following):
Altered stool frequency
Altered stool form (hard/loose)
Altered stool passage (straining/urgency/sense of incomplete evacuation)
Mucous per rectum
Bloating or feeling of abdominal distension
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On the third anniversary 93 of the 99 adults completing the questionnaire were
matched with a control subject. All gastrointestinal symptoms compatible with the
IBS were significantly more frequent in cases. 26 of 93 (28%) cases and 11 of 93
(12%) controls satisfied the modified ROME criteria, [(OR 3.0 (CI 1.3-6.3)], Table
8.2.
8.3.3 Risk factors for new IBS after E. coli 0157 infection
To the third anniversary of infection 55 (37%) of cases had developed new IBS
(Table 8.3). IBS appeared to occur more commonly in female patients, 43 of 104
(41%) females compared to 12 of 45 (27%) males developed IBS but this difference
did not reach statistical significance. Age and indicators of severity during the acute
illness (bloody diarrhoea, abdominal pain, >10 stools/day, diarrhoea > 7 days and
vomiting) were not associated with development of new IBS within 3 years of
infection.
8.3.4 Exclusion of chronic pancreatitis
On the second anniversary 9 of 103 (9%) cases and 13 of 103 (13%) controls had
plasma glucose concentration of over 7.8 mmol/1. 6 (6%) of cases and 13 (13%)
controls had serum amylase over 200 U/l. On the third anniversary 4 of 94 (4%)
cases and 5 of 93 (5%) controls had an elevated plasma glucose. 8 of 94 cases (8.5%)
and 11 of 93 controls (12%) had serum amylase over 100 U/l (new laboratory
reference range). Therefore there were no differences in crude measurement of
pancreatic exocrine or endocrine function.
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8,3.5 IBS and OOL
IBS in cases was clearly associated with reduced QOL. On the second anniversary
cases with IBS had significantly lower mean scores in all eight SF-36 scales
compared to cases without IBS; physical functioning (p=0.01), role physical
(p=0.024), bodily pain (p=0.01), general health (p=0.005), vitality (p<0.001), social
functioning (p<0.001), role emotional (p<0.001), mental health (p<0.001).
Differences in SF-36 scores between the two groups were greatest in those scales
which reflect mental health. On the third anniversary there was no significant
difference on the physical functioning scale between cases with IBS and those
without, however cases with IBS had persistently lower scores for the remaining
scales; role physical (p=0.015), bodily pain (p=0.001), general health (p=0.001),
vitality (p<0.001), social functioning (p<0.02), role emotional (p<0.001), mental
health (p<0.001), Figure 8.3 a, b.
8.4 Discussion
This study shown that E. coli 0157 infection is not only a cause of severe acute
disease but is also responsible for significant ongoing gastrointestinal symptoms.
One year after infection the relative risk of IBS is three times that prior to infection.
The increased prevalence of IBS persists to the third anniversary of infection where
the relative risk of IBS is three times that in the control group.
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Figure 8.3a: Cases SF-36 scores on the 2rd anniversary
jVlatly












The risk of IBS after E. coli 0157 seems to be higher than that after infection with
other gastrointestinal pathogens. To the third anniversary of infection we
documented new IBS in 37% of cases compared with the 4 to 7% rate of new IBS
diagnosed after infection with Campylobacter, salmonella and shigella [Neal et al.
1997, Rodriguez and Ruigomez, 1999], The development of IBS does not appear to
be related to the severity of gastrointestinal symptoms during acute infection. There
was no evidence that chronic pancreatic disease contributed to patients symptoms.
Four cases were referred by their general practitioners for barium enema or
colonoscopy suggesting that their symptoms were sufficiently severe to warrant
further investigation. No structural colonic pathology was identified.
The study may have over estimated the prevalence of IBS after E. coli 0157
infection. There are four potential reasons for this, which have been addressed.
Firstly female sex, an established risk factor for IBS, was over represented in cases
infected with E. coli 0157 during the central Scotland outbreak and consequently
70% of cases on the study were female. Secondly, because patients identified the
variable nature of their symptoms, they were often unable to complete the part of the
questionnaire that recorded symptom frequency, and we therefore did not require that
patients specified a minimum symptom frequency to meet the modified ROME
criteria for IBS. Thirdly, only two thirds of all outbreak cases of E. coli 0157 agreed
to participate in the study and we may have introduced a selection bias for subjects
with ongoing symptoms. Finally, subjects who dropped out between the first and
third anniversaries may represent cases with no symptoms. The methods addressed
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each of these four areas of possible bias. The control population matched the case
cohort in gender, thus excluding female sex as a source of bias. A separate (not
presented) analysis of our data, that required a minimum symptom frequency of once
per week, confirmed that on the second anniversary of infection all gastrointestinal
symptoms were still significantly more prevalent in cases after A. coli 0157
compared to controls and on the third anniversary abdominal pain and loose watery
motions were significantly more common. Additionally the prevalence of IBS in the
control population was within the range (8 to 21 %) expected for western adults
[Jones and Lydeard, 1992, Thompson and Heaton, 1980] which confirms that the
diagnostic criteria were adequate. With respect to bias introduced by attracting cases
with ongoing symptoms, cases attended primarily for monitoring of renal function
and the information sheet that accompanied the invitation for review did not focus on
the possibility of ongoing gastrointestinal symptoms. Also cases who took part in the
study were representative of all infected cases in terms of the severity of their acute
gastrointestinal symptoms. Of the cases who were lost to follow-up, eight (25%) had
IBS on the first anniversary review which suggests that the lost cases do not reflect
the asymptomatic cases. Although the prevalence of IBS may still have been
overestimated, female preponderance, the exclusion of minimum symptom frequency
and "personal significance" bias could not explain the increase in prevalence of IBS
after infection compared to before. This could have been explained by inaccurate
patient recall of symptoms prior to infection, however patient recall of their
symptoms prior to infection was not statistically different in the control group.
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The development of IBS after E. coli 0157 infection is likely to be multifactorial. In
the first instance, a delayed return to normal of colonic function may occur after the
initial destabilisation of the colonic microflora by the invading pathogen [King and
Hunter, 1996], Symptoms could ensue from altered bacterial fermentative activity
with increased gas production. There are a number of theories on perpetuating
factors. Studies have suggested that there is a subgroup of patients with IBS who
have persistently increased concentrations of inflammatory cytokines including
interleukin 1, which by inhibiting absorption of sodium and water could contribute to
persistent diarrhoea [Collins, 1994], Studies in animals have also shown that enteric
infection can lead to persistent dysfunction of neuromuscular tissues [Collins et al.,
1992, Vallance et al., 1994], Bile acid malabsorption, which usually occurs in patient
with disease of the terminal ileum or post cholecystectomy, has recently been shown
to be associated with post infective IBS [Niaz et al., 1997], Gallbladder disease has
now been documented in patients post E. coli 0157 [Tarr, 1995] and bile acid
malabsorption may be responsible for ongoing gastrointestinal symptoms in at least
some of the patients after E. coli 0157 infection. Psychological factors may also be
important [Gwee et al., 1996], Patients who have IBS six months after infectious
gastroenteritis have been shown to have higher scores for anxiety, depression,
somatisation and neurotic trait than those who returned to normal bowel function.
A clear association between IBS post E. coli 0157 and reduced QOL was
demonstrated, with a measured detrimental effect on both physical and mental health.
This is in keeping with recently published data on cases with idiopathic IBS, who
have lower SF-36 scores than the U.S. general population in all scales, and lower
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scores in physical scales than patients with diabetes mellitus and end stage renal
disease [Grainek et al., 2000], The study findings offer insight into the legacy of
gastroenteritis with E. coli 0157, not only does it cause severe acute gastrointestinal
symptoms, but also it generates chronic gastrointestinal symptoms which have a
negative bearing on functional status and well-being.
There is conflicting evidence from small studies on the long-term prognosis of
patients with an acute diarrhoeal onset of IBS. Two studies have shown that patients
tend to have a good prognosis, either improving spontaneously or responding to a
high fibre diet [Gwee et al., 1996, Harvey, 1987], However a third small study,
which reviewed patients with IBS after salmonella to 5 years post infection, showed
that 9 of 11 patients still had disturbed bowel function, and 7 out of 11 still had
abdominal pain [McKendrick, 1996]. Our finding that the prevalence of DBS had
further increased at two years and that a further 21 cases had developed IBS between
the first and third anniversary suggests that IBS post E. coli 0157 infection is
unlikely to be a short term problem. It is therefore suggested that all individuals
involved in this study should be followed up so that meaningful conclusions can be
made about their long-term prognosis, both in terms of gastrointestinal dysfunction






Outbreaks are often fertile sources of new research questions and translating the
questions into a research agenda is an important part of the outbreak legacy.
Outbreaks in conception, however, are unpredictable and do not conform to
traditional research design. The central Scotland outbreak was overwhelming for the
patients affected, the responsible professionals and the local community; therefore
some reservations on the data and the methods are inevitable. The conclusions drawn
from the previous chapters have already been made. This chapter summarises the
findings from the chapters with reference to the original objectives set out in the
general introduction, explores the limitations of the study methods and the prospects
for future research.
9.2 Risk factors for HUS in adults infected with E. coli 0157
The identification of the population at risk of HUS determines their need for
supervision and intervention and facilitates their access to appropriate health care
settings. Children and older adults are known to be at greater risk of HUS and this
was clearly demonstrated in the community and hospital studies of the central
Scotland outbreak. The reasons for increased risk of HUS in these age groups remain
unclear and subject to investigation. Initial speculation that it might reflect higher
Gb3 concentrations at age extremes has not been verified [Boyd and Lingwood,
1989], Our finding that cases on acid lowering drugs or with previous gastrectomy
were at increased risk of HUS was unexpected. Hypochlorhydria may contribute to
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the association of HUS with age as children and the elderly are known to have lower
levels of gastric acid. The hospital study suggest that patients on acid lowering drugs
should be closely observed irrespective of their age.
The association of preceding antibiotics with HUS requires verification in further
studies. If the antibiotic was given for another infection in the days prior to
acquisition of E. coli 0157, subinhibitory concentrations may be found in plasma.
Numerous studies have shown that subtherapeutic concentrations of quinolones,
cotrimoxazole, cefixime, tetracycline and fosfomycin markedly increase the release
of verotoxin [Waterspiel et al., 1992, Karch et al., 1986, Yoh et al., 1999], One study
reported a 10-60 fold increase in VT production in the presence of subinhibitory
concentrations of ciprofloxacin [Yoh et al., 1999], Subinhibitory concentrations of
ciprofloxacin would be unusual in the context of active treatment as the
recommended dose of quinolones are greater than 100 MIC, unless the VTEC has
acquired resistance. This role of subinhibitory antibiotics in vivo is purely
speculation, which the investigation of further outbreaks should clarify. In the
meantime it seems reasonable to consider that those pre-treated with antibiotics are at
increased risk of HUS.
The role of antibiotics in the treatment of E. coli 0157 is equally complex. There is
growing evidence that the effect of antibiotics may be dependant on their mechanism
of action. This in vitro evidence has shown quinolones increase the release of
verotoxin not only in subtherapeutic concentrations but also at concentrations used
for treatment [Kimmitt et al., 1999], The hospital study was unable to further
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implicate quinolones in the pathogenesis of HUS induced by E. coli 0157. Current
UK guidelines on the treatment of gastroenteritis recommend that elderly patients
with bloody diarrhoea be treated with ciprofloxacin [Farthing et al., 1996], This
might prove to be incorrect advice if the infecting organism is E. coli 0157 and
ciprofloxacin increases the risk of HUS in an already predisposed group. This
clinical dilemma could be resolved by a randomised controlled clinical trial.
9.3 The earliest laboratory predictors for the development of HUS
Early identification of laboratory predictors of progression to HUS is vital and could
select cases for trials of preventative and treatment therapies. A number of studies in
children have shown that elevated WCC is associated with HUS. There has been
only study, prior to those reported here, which made the observation that elevated
WCC preceded HUS. The observation was made during an outbreak in children
where 8 of 20 cases developed HUS [Pavia et al., 1989], Children who developed
HUS had high WCC and fever on day three of illness, two days before the onset of
recognisable HUS. The studies reported in chapters 3 and 4 clearly confirm that high
WCC is a precursor to HUS, not only in children but also in adult cases.
The findings of an early rise in WCC will contribute to the investigation of the
pathogenesis of HUS. The white cell response is reminiscent of leukemoid reaction
seen in patients with FTUS after S. dysenteriae type 1 [Koster et al., 1978, Butler et
al., 1987], The response would be consistent with toxin mediated activation of
neutrophils and there is growing evidence that this is a central mechanism of HUS
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[Forsyth et al., 1989], Neutrophilia at the onset of HUS correlates with poor
prognosis; 50% of the variance of outcome in one study was explained by this
parameter alone [Coad et al., 1991], At the 4th International symposium on VTEC,
in vitro evidence was presented that VT2 binds exclusively to a single class of
binding sites on neutrophils and it seems likely that this is the mode of transfer of VT
from the intestine to endothelial cells [Monnens, 2000],
The studies presented in Chapters 3 and 4 also define more clearly the evolution of
laboratory abnormalities. This work is the first to illustrate that falling platelets and
haemoglobin, which are within the definition of HUS, are the last manifestations of
the syndrome and cannot be relied upon for early detection.
During the Sakai City outbreak in Japan in 1996, retrospective analysis found an
elevated C reactive protein (CRP) to be predictive of the development of HUS in
children [Ikeda et al., 1999], In one study 46% of children with CRP greater than 2
mg/dl developed HUS [Kawamura et al., 1999], The measurement of CRP is now
widely available in the hospital setting. CRP could prove additive to WCC in
determining those at greatest risk of HUS. The value of CRP in determining
prognosis should be investigated further.
The observation that hypoalbuminaemia is an early marker of HUS is new. It
remains unclear whether this reflects severe gastrointestinal infection, systemic
sepsis or is simply a manifestation of low albumin in older age groups. None of the
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studies in children have reported albumin levels in patients with HUS. Future studies
should evaluate albumin as this may prove an early indicator of incipient HUS.
9.4 Protocol for monitoring patients in the community to identify those at
risk of HUS
Community monitoring in the central Scotland outbreak employed enormous
resources already limited by the outbreak situation. It is impossible and unnecessary
to monitor intensively all patients with disease symptoms. The studies reported in
chapters 3 and 4 have identified risk factors for severe disease. A monitoring strategy
can be proposed based on the expectation that complete HUS is usually established
seven days from the onset of diarrhoea but progressive abnormalities are likely to be
evident at an earlier stage.
For suspected A. coli 0157 infection;
• All patients should have a stool culture performed.
• FBC, film, LDH, CRP, urea and creatinine should be checked at presentation if
> aged <15 or >64 years.
> aged 15-64 years with low gastric acid levels, immunosuppression or clinical
evidence of severe disease.
• Patients with high WCC or red cell fragmentation should have all blood tests
repeated every two days until 14 days after the onset of symptoms, unless all
abnormalities clearly resolve during that time.
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• Patients should be referred to secondary care if laboratory parameters indicative
of HUS are clearly developing.
• Cases with normal blood results on presentation need have them repeated only if
their clinical condition deteriorates.
This strategy is limited by observations from the studies;
> Patients aged between 15 and 65 years might develop HUS.
> 5 per cent of HUS patients never have an increased WCC response.
A monitoring protocol might not initially identify all patients who develop HUS;
therefore, it is essential that all patients with suspected E. coli 0157 infection are
fully informed of potential complications and are cautioned to re-present for
monitoring if their clinical condition deteriorates within the 14 days following the
onset of their symptoms. This advice is limited by the fact that the early clinical
features of HUS are non-specific and patients cannot be given clear guidelines based
on symptoms alone.
The recommendations for monitoring patients with suspected E. coli 0157 infection
are based on current best evidence, but these could change with new information.
Analysis of the Japanese outbreak found patients who developed HUS had high
circulating levels of thrombomodulin and endothelin, compounds released by
activated or damaged endothelial cells [Honda, 1999], Although measurement of
these compounds is currently a research technique, they could be incorporated into
future clinical diagnostic procedures.
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The main aim of employing a protocol in the management of future outbreaks of E.
coli 0157 infection is to identify as accurately as possible patients at high risk of
developing HUS. It is important to specify the value of accurate prediction.
Currently early diagnosis allows patients to receive early supportive therapy and
potentially beneficial therapy such as TPE. Specific therapies based on knowledge
of the pathogenesis of HUS are being evaluated [Armstrong et al., 1995, Takeda et
al, 1999].
9.5 The role of therapeutic plasma exchange in the treatment of adults who
develop HUS in the context of E. coli 0157 infection
The mortality associated with HUS in children has improved dramatically in the last
two decades, and this has been attributed to improved dialysis techniques. It is
unlikely that the mortality from HUS will be improved further by dialysis alone as
most deaths are now due to neurological complications. Future improvement in
outcome will be dependent on intervention that modifies the neurological
complications of HUS.
The role of TPE in children with diarrhoea associated HUS has been controversial. A
controlled trial of plasma infusion in children did not show benefit [Rizzoni et al.,
1986], This was a study of 32 children with HUS, 17 of who received plasma and 15
symptomatic treatment only. There were no deaths in either group and the study had
limited power to determine differences between the two treatment modes. TPE
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involves removal of patients' plasma in addition to infusion of donor plasma. It is still
unclear whether the benefit of TPE is due to removing an injurious factor from the
patient's plasma, infusing a factor deficient in the patient but contained in the donor
fresh frozen plasma (FFP) or both. In recent years TPE has been shown to be superior
to plasma infusion in the treatment of idiopathic, drug induced and pregnancy
associated TTP [Bell, 1997, Remuzzi and Ruggenenti, 1995, Rock el al., 1991],
Therefore the accepted standard of care for idiopathic TTP is TPE, and this
intervention has reduced mortality from 90% [Amorosi and Ultman, 1966] to
between 10-20% [Bandarenko et al., 1998], There were no reports of the use of TPE
inE. coh 0157 infection.
There is concern that the pathogenesis ofHUS differs, depending on the precipitant of
the syndrome. There is concern that VTEC induced HUS is different in its pathology
from the forms for which there is evidence that TPE is effective. It has been
suggested that apoptosis and vWF multimers do not occur in VTEC induced HUS;
therefore, TPE would not be effective [Laurence, 2000, Laurence and Mitra, 1997],
There is very little evidence on the pathogenesis ofE. coli 0157-induced HUS. Some
investigators have demonstrated verotoxin induced apoptosis in human microvascular
endothelial cells pre-exposed to TNF-a [Van de Kar and Monnens, 1998, Mahn el al.,
1996, Inward et al., 1995], and large vWf multimeric forms have been shown to occur
in plasma in E. coli 0157-associated HUS [Moake el al., 1994], Perhaps more
importantly, there is no consensus that the effectiveness of TPE is dependant on its
ability to reverse apoptosis. The conflicting reports raise interesting questions about
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the pathogenesis of HUS, but they present no definitive evidence that aetiological
distinction is related to pathological distinction and, therefore, response to TPE.
To date TPE has not been subjected to clinical trials in E. coli 0157-related HUS. In
adults mortality from VTEC associated HUS was recorded at 88%, and
commensurate with early outcomes from idiopathic forms of HUS. In adults in the
Lanarkshire outbreak, TPE was a valuable intervention; however, this was not a
randomised, controlled clinical trial. During the 1996 E. coli 0157 outbreak in Japan,
4 of 12 children who developed HUS in one hospital received only plasma exchange.
All 4 had a favourable outcome and 3 of the 4 improved promptly after the
introduction of TPE [Fukushima et al., 1999], VTEC associated HUS in children now
generally responds to dialysis and TPE might not be routinely indicated in this age
group. There is growing evidence for the effectiveness of TPE in all age groups, and
there is a stronger case for use of TPE in adults among whom mortality remains high.
The clinical efficacy, or otherwise, of TPE in E. coli 0157-associated HUS needs to
be determined definitively. Certainly there is no convincing evidence, from current
understanding of the pathogenesis or clinical evidence, that TPE could not be
effective. Enhanced surveillance of HUS in Scotland will soon be implemented by
SCIEH. Similar surveillance was previously operative in children throughout the UK.
HUS surveillance in Scotland will be a clinically driven system and it is hoped that it
will provide prognostic clinical and treatment outcomes, which will assist cost benefit
analysis of intervention strategies, particularly the role of TPE.
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9.6 Genetically mediated inflammatory responses of individuals associated
with the severe disease
In Chapter 6 two genetic markers were identified in significantly higher proportions
of patients in the Lanarkshire outbreak, blood group O and absence or weak
expression of the PI antigen or erythrocytes. The association with group O does not
appear to be related to increased bacterial binding to epithelial cells as has been
observed for H. pylori. Over 80% of patients with HUS had no or low levels of PI on
their erythrocytes. In vitro TNFa responses induced by culture filtrates of the
outbreak strain from leukocytes of blood donors whose erythrocytes were Pl-
negative were significantly higher than those ofP-positive donors.
Approximately 75-80% of the normal Caucasian population express blood type PI
on erythrocytes but the antigenic strength varies considerably. The P antigen is
structurally similar to Gb3 the verotoxin receptor. It is expressed only on a few cell
types, particularly on erthrocytes, monocytes, some parts of the vascular
endothelium, and on renal glomerular cells of infants. The sites and strength of
expression vary with age. The association with weak or absent expression of PI and
HUS would be expected from our understanding of verotoxin receptors. Contrary to
our findings, a study from Japan found no association between PI blood group
antigen and HUS; however, the prevalence of PI blood group in Japan is low (35%)
and the study was small, factors which may have limited the conclusion [Ashida et
al., 1999],
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There is compelling evidence for cytotoxic and inflammatory events in the
pathogenesis of HUS, and it is reasonable to look for links between them. Both
lipopolysaccharide and the cytokines TNFoc and interleukin 1(3 stimulate human
glomerular endothelial cells to increase the surface expression of verocytotoxin
receptors thus making them more vulnerable to cytocidal effects [van Setten et al.,
1997]. Just as inflammatory events have the potential to increase cytotoxicity, so too
is there a pathway by which verocytotoxin can induce an inflammatory event and
several studies have found high levels of TNFa, IL-6 and IL-8 in the plasma and
urine of children with HUS. High levels of TNFa (> 100 IU/ ml) produced by
leukocytes of PI negative donors suggests that PI blood group is indeed important in
VTEC induced HUS. This observation and the significant excess of group O among
the patients who died need to be examined in future studies.
9.7 Chronic renal function abnormalities in adults after E. coli 0157
induced thrombotic microangiopathy
Chronic renal disease occurred after HUS in the population studied [Chapter 7], The
implications for the cases presented and overall prognosis cannot yet be determined.
No case was dependant on dialysis at the time of reporting. With longer follow up
the abnormalities detected may become clinically important. It is reasonable to
speculate that if the histological abnormalities detected in children are present in
adults, renal decline is inevitable and this decline could be exaggerated by
atherosclerosis in older age groups. Annual review of renal function for all patients
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with HUS is recommended. Enhanced surveillance of HUS in Scotland may give
further insight into the long term prognosis of VTEC induced disease in adults.
9.8 IBS after E. coli 0157
This is the first study to identify IBS after E coli 0157 [Chapter 8], The severity of
acute disease and reports from other pathogens suggested that chronic
gastrointestinal symptoms could occur. A large proportion of cases developed IBS
after disease due to E coli 0157. The study could have over estimated the prevalence
of this complication, but IBS appears to be more common after E. coli 0157
infection than after disease due to other gastrointestinal pathogens.
Ongoing gastrointestinal symptoms may be functional, a legacy of colonic
inflammation, perpetuated by bile acid malabsorption or pancreatic exocrine
insufficiency. The study assessed bowel symptoms up to three years after infection,
and in that time no structural colonic lesion was identified in the small number of
patients who underwent further investigation. Colonoscopic examination during
acute E. coli 0157 infection shows right sided disease. The histological features are a
mixture of ischaemic and infectious changes [Griffin et al., 1990], Ischaemic colitis
is a recognised precursor to colonic stricture formation [Simi et al., 1995] and
colonic strictures have been described following disease due to E. coli 0157. One
small study of diarrhoea and bile acid malabsorption confirmed gastrointestinal
infection with Campylobacter, salmonella or shigella in six of 84 cases [Niaz et al.,
1997], Bile acid malabsorption may play a greater role in diarrhoea after E. coli
136
0157 as gallbladder disease has been confirmed during the acute illness. Therefore in
some of our patients, it is possible that their symptoms are not purely functional but a
precursor for later disease and a low threshold should exist for further investigation
of ongoing gastrointestinal symptoms.
9.9 The effect of E. coli 0157 infection on future quality of life
A reduced quality of life was noted among the patient population studied, and this
can be linked to symptoms of IBS. IBS is not life threatening but has a significant
impact on medical resources. In our patients, all SF-36 scales were lower than those
reported in subjects in the UK with idiopathic IBS [Akehurst et al., 2002] (figure
9.1). The reasons for this observation remain unclear, perhaps our patients have
lower QOL because their gastrointestinal symptoms are not purely functional. All
SF-36 scales were lower in our patients without IBS than UK normative data, an
observation that might be explained in part by the fact that this group included 6
cases who had HUS.
9.10 Costs
E. coli 0157 imposes considerable cost on the physical and mental well being of the
affected individuals. The financial costs are also substantial and cannot be ignored.
Study of an outbreak from Scotland in 1994 investigated cost of complications
[Roberts et al., 2000], The average cost per patient who developed HUS was £62 353
compared with £1030 in those who had uncomplicated disease. The cost per
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hospitalised patient was £8417. The cost of TPE was estimated as £2500 per patient.
It is impossible to put a price on the cost of premature death. The cost of chronic
renal disease and IBS cannot yet be predicted as the severity and prevalence of these
complications is presently unclear. When the consequences of infection are so
enormous all efforts should be targeted at prevention. There is evidence that
preventative strategies implemented after the central Scotland outbreak are taking
effect.
9.11 Future studies
The information presented identifies areas for future research:
1. Effects of subinhibitory levels of different classes of antibiotics on release of
endotoxin as well as VT and the effects of these on inflammatory responses.
2. Effect of low levels of gastric acid on release of VT.
3. Correlation between high CRP and WCC and inflammatory responses (IL-8,
TNF, IL-1B, IL-10) in serum of patients.
4. Combined predictive value of CRP and WCC in determining risk ofHUS.
5. Albumin levels in children as a marker of severe disease or HUS.
6. Prospective study of all adults with HUS to determine acute and chronic
outcomes and effectiveness of TPE.
7. Randomised controlled clinical trial of ciprofloxacin in adults with E. coli
0157 to determine risk of HUS.
8. Interactions between different endotoxin O types and VT in relation to
induction of pro-inflammatory cytokines.
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9. Assessment of pro- and anti-inflammatory gene polymorphisms among
patients with E. coli 0157 disease, and relation of severity of disease to
inflammatory mediators in serum during acute stage of the infection.
10. Measurement of IL 1 in patients with ongoing gastrointestinal symptoms.
11. Measurement of faecal bile acids and faecal pancreatic enzymes in patients
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SUMMARY
During outbreaks of Escherichia coli 0157 a minority of patients with suspected infection
develop haemolytic uraemic syndrome (HUS). The ability to identify this subgroup at an early
stage is beneficial as mortality from HUS is high and may be influenced by intervention.
During the 1996 Central Scotland E. coli 0157 outbreak, of 886 patients from the community
with suspected infection monitored at an outbreak clinic, nine developed HUS. We assessed
factors associated with the development of HUS in this group. Children and the elderly were
at increased risk of HUS. However, high white cell count was as least as good a predictor of
HUS as age. High white cell counts predicted development of HUS with a sensitivity of 89%,
specificity of 87%, positive predictive value of 7% and a negative predictive value of over
99%. We have used the results from this study along with other currently available evidence to
propose a monitoring protocol for patients from the community with suspected E. coli 0157
infection.
INTRODUCTION
Since Escherichia coli 0157 (E. coli 0157) was first
recognized as a cause of gastroenteritis in 1982 [1] it
has become increasingly identified as a significant
threat to the public health. Of patients with symp¬
tomatic infection approximately half have non-bloody
diarrhoea whereas the remainder develop haemor-
rhagic colitis [2]. An estimated 2-7% of patients with
symptomatic infection develop the life-threatening
renal complication, haemolytic uraemic syndrome
(HUS), or neurological complications, previously
referred to as thrombotic thrombocytopenic purpura
(TTP) [3]. HUS and TTP are different clinical
manifestations of the same pathological microvascular
process, due to systemic absorption of the Shiga toxin
* Author for correspondence: Information and Statistics Division,
Trinity Park House, South Trinity Road, Edinburgh, EH5 3SQ.
produced by E. coli 0157 [4, 5], and are now uniformly
referred to as HUS in the context of this infection.
Scotland has one of the highest incidences of
reported E. coliO\51 infection in the world [6]. Whilst
most reported cases are sporadic [7] outbreaks
continue to occur. In 1996 the largest outbreak to date
in the United Kingdom occurred in central Scotland
[8]. The outbreak involved 512 cases (337 confirmed
or probable cases), of whom 34 developed HUS and
22 died (17 deaths were considered to be directly
attributable to E. coli infection at the Fatal Accident
Enquiry that followed the outbreak).
Early in the course of the outbreak the source of
infection was traced to a butcher's shop in Wishaw,
a town in Central Scotland with a population of
approximately 50000. The majority of cases lived in
Wishaw and the surrounding area and understandably
there was a great deal of public anxiety about the
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Table 1. Case definition status of the 245 cases monitored at the community clinic
Stool specimen negativet
Symptoms Stool specimen positive* Serology positive]: Serology negativet
Asymptomatic or no Confirmed (19) Possible (23) Not a case
history
Non-bloody diarrhoea Confirmed (51) Possible (15) Not a case
only
Bloody diarrhoea Confirmed (72) Probable (28) Possible (37)
and/or HUS
* For the outbreak strain (E. coli 0157:H7, phage type 2, verocytotoxin type 2 producing, DNA profile by pulse-field gel
electrophoresis characteristic of the outbreak strain) either by primary culture or immunomagnetic separation.
t Or not done.
{ Or post-mortem evidence of infection with the outbreak strain.
outbreak within the town. To ease pressure placed on
local primary- and secondary-care services a special
community outbreak clinic was established in the
local health centre. The clinic aimed to support the
public health investigation, facilitate the provision of
consistent public health advice to minimize secondary
spread of the infection, and co-ordinate the care of
cases.
The outbreak clinic was principally used to monitor
patients from the local community with clinically
suspected E. coli 0157 infection. A patient with onset
of diarrhoeal illness since the start of the outbreak was
defined as having suspected infection and these
patients could be referred to the clinic by their GPs. In
addition the clinic was also used by patients required
to submit samples for work exclusion purposes, and
to follow up after discharge a number of known cases
who were admitted to hospital early in the course of
the outbreak.
A protocol to guide the management of patients
with suspected E. coli Ol 57 infection was drawn up at
the start of the outbreak and was used consistently at
the clinic. The protocol specifically aimed to confirm
that patients fulfilled the case definition, ensure early
diagnosis of HUS, and facilitate prompt and ap¬
propriate referral of patients requiring secondary
care.
Stool microbiology and paired serology were
performed to establish whether patients fulfilled the
case definition (Table 1). Stool culture on Sorbital
McConkey agar was performed locally, but other tests
such as stool Immunomagnetic Separation, and
serology were carried out at the Scottish E. coli 0157
reference laboratory in Aberdeen. Due to delays in
receiving final results from the reference laboratory, at
the time patients were attending the clinic, whether
they fulfilled the case definition was often still
unknown.
To monitor for HUS, all patients with suspected
infection had their haemoglobin, white cell count
(WCC), platelets, blood film, lactate dehydrogenase
level (LDH), and serum urea and creatinine checked
every 2 days for 14 days. Standard criteria were
developed to guide referral to secondary care. Referral
was recommended for patients with severe clinical
manifestations of infection (such as dehydration
requiring parenteral fluid management) and patients
whose laboratory findings indicated the imminent
development of HUS (such as a rising LDH level of
falling platelets) [8],
Previous studies have identified risk factors for
HUS in patients with known E. coli 0157 infection.
Young children and the elderly have consistently been
found to be more likely to develop HUS than young
adults [2,3,9]. Studies involving children have
suggested that a raised WCC early in the course of
illness is also associated with an increased risk of HUS
[10-12]. A high WCC has also been consistently
shown to be an adverse prognostic indicator in
hospitalized children with HUS secondary to E. coli
0157 infection [13-15]. WCC in adults with E. coli
0157 has never been assessed.
Gender, the presence of haemorrhagic colitis or
fever, or the use of antimotility agents have been
inconsistently associated with higher risk of HUS
[2, 3, 11], Retrospective analysis of all hospitalized
cases from the Central Scotland outbreak suggested
that patients taking antacids were at increased risk of
HUS [16]. There is a lack of agreement regarding the
role of antibiotics in HUS [17, 18] and it now seems
that antibiotics of specific classes will have harmful
and beneficial effects.
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All the data relating to the patients monitored at
the Wishaw clinic during the central Scotland out¬
break have been validated and linked by the In¬
formation and Statistics Division of the NHS in
Scotland [19]. The data include patients' demographic
features, limited clinical information such as the
presence or absence of bloody diarrhoea, and all
microbiological, biochemical, and haematological
results. The data provide a unique opportunity to
examine the features associated with the subsequent
development of HUS in patients from a wide age
range with suspected E. coli 0157 infection.
We examined the ability of age and patients' WCC
to predict the development of HUS in suspected
infection. We have not examined other clinical
features in detail. A separate analysis of all cases
hospitalized during the central Scotland outbreak has
shown no other significant association between these
clinical features and subsequent development of HUS
[16].
SUBJECTS AND METHODS
Patients with suspected E. coli 0157 infection (but not
with established HUS) who were referred from
primary care to the Wishaw clinic for monitoring were
included in the study.
The case definitions employed during the outbreak
and the number of cases meeting each definition are
shown in Table 1. For this study a case was defined as
any patient meeting the confirmed, probable, or
possible case definitions.
During the outbreak and for the purposes of this
study HUS was defined as follows:
(i) red cell fragmentation on blood film, and lactate
dehydrogenase > 1-5 times the upper limit of
normal;
(ii) thromocytopenia (platelets < 150x 10!,/1);
(iii) acute renal impairment (urea and creatinine
above the normal range and rising) and/or new
neurological signs.
The day on which all three criteria were met was
deemed the day of onset of HUS.
The socio-economic status of patients was assessed
by converting postcodes of residence into deprivation
categories using the Carstairs and Morris index [20].
Deprivation categories are ranked 1-7, with 7 repre¬
senting the most deprivation.
We first assessed the association in patients with
suspected infection between age, gender, and presence
1198 presented
\ 229 advice only
969 formally assessed
\ 36 no blood samples
933 blood test monitoring
| 46 referred from hospital or referral source unkown
887 referred from primary care
| 1 in established HUS at time of referral
886 suitable for inclusion in the study




Fig. 2. The age and gender distribution of patients
monitored at the community clinic.
of bloody diarrhoea, and subsequent development of
HUS. We next mapped the clinical course of the
patients who developed HUS in detail to identity
which laboratory parameters became abnormal first.
We then specifically assessed how well the WCC
predicted the development of HUS in patients with
suspected E. coli 0157 infection.
The sensitivity, specificity, and predictive values for
a patient having one or more abnormally high WCC
prior to the onset of HUS were calculated. An
abnormally high result was defined as one above the
age appropriate reference range specified by the local
laboratory (reference ranges available on request).
The exact method for calculating a confidence interval
for a single sample proportion was used to calculate
95% confidence intervals for all results [21], The
analysis was repeated using neutrophil count rather
than total WCC. Finally we assessed how well age and
WCC considered together identified patients at
highest risk of developing HUS.
RESULTS
In total 1198 people presented to the Wishaw clinic.
Of these 229 did not meet the clinic's criteria for
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Table 2. The proportion ofpatients (cases) monitored at the community
clinic that developed /IUS; by presence of bloody diarrhoea
Number of patients (cases) Number that
Bloody diarrhoea monitored at the clinic developed HUS
Present 133 (133) 6 (6)
Absent 753 (112) 3 (3)
Total 886 (245) 9 (9)
Fisher's exact test for all patients, P < 0 001.
Fisher's exact test for cases, P = 0-514.
assessment. A further 36 people had no blood samples
taken. This group includes people required to submit
microbiological samples only for possible work ex¬
clusion purposes. Therefore, 933 people underwent
blood test monitoring according to the clinic protocol.
Of the 933 patients 39 were referred from hospital for
post discharge follow up. For seven patients it was
unknown whether they were referred from primary or
secondary care. The remainder were known to be
referred from primary care. One person referred from
primary care had established HUS at the time of
referral so no information could be obtained on the
features predating the development of HUS. Overall
886 patients were eligible for inclusion (Fig. 1).
This group is representative of patients presenting
to primary care with suspected E. coli 0157 infection
during a community based outbreak. Of the 886
patients monitored, 245 were cases, of which 170
(69%) had confirmed or probable infection (Table 1).
Twenty-seven of the cases were admitted to hospital,
9 developed HUS, and 2 died.
The age and sex distribution is shown in Figure 2.
Of the patients monitored 89 % were resident in areas
assigned deprivation category 5 or 6. This reflects the
fact that Wishaw and its surroundings is a relatively
deprived area of Scotland.
Men (3/346) and women (6/540) monitored at the
clinic were equally likely to develop HUS (Fisher's
exact test P = 1-0). Children < 15 years and adults
> 64 years (7/298) however were significantly more
likely than adults aged 15-64 years (2/588) to develop
HUS (Fisher's exact test P = 0 008).
The presence of bloody diarrhoea was significantly
associated with development of HUS in all clinic
attendees. However, bloody diarrhoea was not found
to be significantly associated in the subset of persons
fulfilling the case definition (Table 2). Three of the
nine cases that developed complications progressed
straight from non-bloody diarrhoea to HUS without
having haemorrhagic colitis.
In terms of assessing the ability of laboratory
parameters to predict HUS, we initially examined in
detail the clinical course of the nine patients that
developed complications (Table 3). The median
interval between onset of symptoms and onset of
HUS was 9 days (range 5-15). In general an elevated
WCC preceded the development of HUS and also
preceded changes in urea, creatinine, LDH, hae¬
moglobin, and platelet levels, and the appearance of
fragmented red cells (Table 4).
Eight of the nine patients with HUS had a high
WCC at some point during their illness. In all eight
the WCC became abnormal before the onset of HUS,
a median of 15 days after the onset of symptoms, and
5 days (range 1-8) before the onset of HUS. In 7 of the
8 patients (the exception was a patient who did not
develop a raised WCC until 14 days after the onset of
symptoms) the WCC was abnormal on the first blood
sample, obtained when the patients presented. These
findings are compatible with results from the
hospitalized cases, in whom the WCC on day two of
illness was significantly higher in cases who developed
HUS, preceding changes in other laboratory markers
by several days [16].
The presence of one or more high WCC results
predicted the subsequent development of HUS in all
clinic attendees, with a sensitivity of 89%, specificity
of 87 %, positive predictive value of 7 %, and negative
predictive value of over 99% (Table 5). A high WCC
similarly predicted the subsequent development of
HUS in the cases, monitored at the clinic (Table 5).
As it is specifically neutrophils that are implicated
in the pathophysiology of complicated E. coli 0157
infection [22,23], we also assessed how well the
neutrophil count predicted the development of HUS.
We found that the neutrophil count was not signifi¬
cantly better than the total WCC in predicting HUS.
Finally, as age group and WCC are the features
most strongly associated with the subsequent de¬
velopment of HUS, we assessed the predictive value of
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definition Clinic HUS WCC Hb
Fragmented
red cells LDH Platelets Urea Creatinine
1 70 F Yes Confirmed 0 5 0 5 3 4 5 2 5
2 70 M Yes Confirmed 1 5 1 5 5 1 5 1 N
3 63 F Yes Confirmed 3 6 1 1 3 3 6 3 N
4 10 M No Confirmed 2 7 2 N 7 4 7 7 2
5 6 F Yes Confirmed 1 9 1 N 7 1 9 7 1.
6 80 F No Confirmed 4 11 4 11 8 8 11 8 N
7 78 F Yes Probable 5 11 5 8 8 5 10 5 5
8 61 F Yes Confirmed 6 12 N 12 12 10 6 10 10
9 2 M No Confirmed 2 15 14 6 15 10 15 15 2
* Clinic, day of first attendance at clinic; HUS, day of onset HUS: All blood results, day of first recorded abnormal result
(high or low as appropriate); Note all results are based on the day of onset of symptoms being day 0. N, indicates that no
abnormal result for that blood parameter was recorded for that patient at any point during their illness (either before or after
the onset of HUS).
Table 4. Median interval between onset of symptoms and first abnormal result in cases with HUS
Number of patients with an Median interval between
abnormal result recorded onset of symptoms and
at some point during first recorded abnormal
the course of their illness result (days) Range (days)
WCC 8/9
Haemoglobin 8/9












Day 0 is day of onset of symptoms.
* Note that 1 of the 8 patients who developed anaemia only did so after the onset of their HUS.
Table 5. The validity of a high white count result in predicting subsequent
development of HUS in all patients (cases) monitored at the community
clinic




113 (49) 121 (57)
764(187) 765 (188)
877 (236) 886 (245)
Summary of results for all patients
Sensitivity: 88-9% (51-8 997%)
Specificity: 87-1 % (84-9-89-3%)
Positive predictive value: 6-6% (2-9-12-6%)
Negative predictive value: 99-9% (99-3-100%)
Summary of results for cases
Sensitivity: 88-9 % (51 -8-99-7 %)
Specificity: 79-2 % (74-1-84-4 %)
Positive predictive value: 14-0% (6-3-25-8%)
Negative predictive value: 99-5% (97-1-100%)
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age group and WCC combined. The positive pre¬
dictive value of age (< 15 or >64) alone was 7/298
(2-3%, 95% CI 0-9-4-8%); that of WCC alone was
8/121 (6-6%, 2-9-12-6%); and that of age and WCC
combined was 7/50 (14%, 5-8-26-7%).
DISCUSSION
This study is unique in assessing features associated
with the development of HUS in a large number of
patients, from a wide age range, with suspected E. coli
0157 infection monitored in a community setting
during a large-scale outbreak.
We found that children and the elderly with
suspected infection are at higher risk of developing
HUS than young adults. This agrees with previous
work involving patients with known E. coli 0157
infection [2, 3, 9]. We found that bloody diarrhoea is
not a good predictor of HUS and this too is in
agreement with previously published work [24],
Significantly, this study also demonstrates the
importance of a raised WCC as a predictor of HUS,
in patients of all ages with suspected as well as
confirmed E. coli 0157 infection. Raised WCC is
possibly a better predictor of HUS than age. Patients
with normal WCC are at very low risk of HUS.
Additionally development of a high WCC precedes
changes in other laboratory parameters in HUS. This
finding is in keeping with the fact that neutrophils
carry Shiga toxin and therefore are likely to be pivotal
to the pathogenesis of HUS [23]. Our findings thus
confirm the value of laboratory monitoring in patients
with suspected E. coli 0157.
The clinic was invaluable in alleviating pressure on
local services, and ensuring that patients received
consistent information and were monitored and
referred on to secondary care in a consistent way. In
addition it facilitated comprehensive data collection.
We would recommend the establishment of a similar
clinic during any large community based E. coli 0157
outbreak.
The protocol used at the clinic required very
comprehensive monitoring of all patients with sus¬
pected infection, including patients that we could now
identify as being at very low risk of developing HUS.
We would therefore, in future, recommend the
following streamlined monitoring protocol for
patients in the community with suspected E. coli Ol 57
infection, targeting those at extremes of age who
present with high WCC:
(i) All patients should have a stool culture per¬
formed.
(ii) All patients aged < 15 or > 64 years, and adults
aged 15-64 years with low gastric acid levels,
or who clinically appear systemically unwell,
should have their full blood count and film,
LDH, and serum urea and creatinine checked at
presentation. This will identify patients with a
raised WCC (indicating increased risk of HUS)
and those with established HUS.
(iii) Patients with a raised WCC or other significant
abnormality such as evidence of haemolysis
should be clinically reviewed and have all blood
tests repeated every 2 days until 14 days after the
onset of symptoms, unless all abnormalities
clearly resolve during that time.
(iv) Patients should be referred to secondary case if
laboratory parameters indicative of HUS are
clearly deteriorating.
Neither this nor any other monitoring protocol will
identify all patients who develop HUS. Hence it is
essential that in addition all patients with suspected
E. coli 0157 infection are fully informed of potential
complications and are cautioned to represent for
monitoring if their clinical condition deteriorates
within the 14 days following the onset of their
symptoms, since the early clinical features of HUS are
non-specific.
Whilst we believe that these recommendations are
based on current best evidence we recognize that the
situation may develop in the future. For example,
during an extremely large E. coli 0157 outbreak in
Japan in 1996, retrospective analysis found an elevated
C reactive protein (CRP) to be predictive of the
development of HUS in children [25]. CRP may
therefore prove to be a useful additional monitoring
tool for the management of future outbreaks, and its
potential role should be evaluated further. Unfortu¬
nately, however, laboratory methods for the measure¬
ment of CRP are not currently standardized through¬
out the United Kingdom.
Another analysis of the same Japanese outbreak
found patients who developed HUS had high circu¬
lating levels of thrombomodulin and endothelin
compounds released by activated or damaged en¬
dothelial cells [26].
Early diagnosis allows patients to receive early
supportive therapy such as dialysis, and potentially
beneficial therapy such as plasma exchange [27]. Other
specific therapies are currently under development,
such as an oral verotoxin-binding agent now under-
E. coli 0157 in the community 419
going phase III clinical trials [28], These specific
therapies offer the hope of preventing, or improving
the prognosis of, HUS.
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The Central Scotland Escherichia coli
Oi57:H7 Outbreak: Risk Factors
for the Hemolytic Uremic Syndrome
and Death among Hospitalized Patients
Stephanie Dundas,1 W. T. Andrew Todd,' Alastair I. Stewart,1 Peter S. Murdoch,2 A. K. R. Chaudhuri,'
and Sharon J. Hutchinson3
'Department of Infectious Diseases, Monklands Hospital, Lanarkshire, "Department of Geriatric Medicine and District Royal Infirmary, Falkirk,
and "Scottish Centre for Infection and Environmental Health, Glasgow, United Kingdom
Little is known about risk factors for complications of Escherichia coli 0157:H7 infection in adults. The 1996
outbreak in central Scotland involved the largest number of adult case patients in whom hemolytic uremic
syndrome (HUS) developed and, ultimately, the largest number of deaths associated with E. coli 0157:H7
infection that has yet been recorded. We investigated risk factors for HUS in a retrospective study of all
hospitalized case patients in this outbreak. Of 120 case patients, 34 had HUS develop, 28 of whom were adults.
Sixteen adults died. Significant risk factors for HUS were age <15 years or >65 years (odds ratio [OR], 4.4;
95% confidence interval [CI], 1.3-14.4), hypochlorhydria (OR, 6.7; 95% CI, 1.9-24.0), and coincidental an¬
tibiotics (OR, 4.7; 95% CI 1.4—16.5). Factors associated with HUS were as follows: white blood cell count >
20 X 109 cells/L (OR, 8.25; 95% CI, 1.1-60.3), neutrophil count > 15 X 109 cells/L (OR, 8.5; 95% CI, 1.5-50.1),
and serum albumin level <35 g/L (OR, 7.2; 95% CI, 1.2-42.5) <3 days after symptom onset. Deaths were
confined to case patients >65 years of age. Early identification of risk factors for HUS is vital and could select
case patients for trials of preventative and treatment therapies.
In the last decade, infection with Escherichia coli 0157:
H7 has become a significant public health problem in
the developed world. In 2%—15% of cases, gastrointes¬
tinal infection progresses to the hemolytic uremic syn¬
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drome (HUS). HUS is a systemic microvascular syn¬
drome that is initiated by secreted Shiga toxins, with
predominantly renal and neurological complications,
which are responsible for most deaths associated with
E. coli 0157:H7 infection. Early identification of risk
factors that predict progression from gastrointestinal
infection to HUS is vital because there are promising
new therapies: new agents that may block Shiga toxin
absorption to prevent HUS [1] and (controversially)
early therapeutic plasma exchange [2],
In retrospective studies of outbreaks of E. coli 0157:
H7 infection, age (<5 years or >65 years) and elevated
white blood cell count (WBC) have consistently been
reported as risk factors for HUS [3-9]. There is dis¬
agreement regarding antibiotic therapy [5, 6, 10-18],
therapy with antimotility agents, fever, bloody stools,
vomiting, and sex as other potential risk factors in the
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Figure 1. Age distribution of patients infected with Escherichia coli
0157:H7 who were admitted to the hospital and who developed systemic
complications. HUS, hemolytic uremic syndrome; TMA, thrombotic micro¬
angiopathy.
progression to HUS [6, 11, 12, 19, 20]. To date, most reports
relate to the pediatric population, and features of adult disease
are essentially unknown.
The 1996 outbreak of E. coli 0157:H7 infection in central
Scotland originated in a retail source in which cooked meats
were cross-contaminated. The first group within the outbreak
cohort was composed of elderly people infected at a Christmas
church lunch, but ultimately the outbreak spread to affect peo¬
ple of all ages. The outbreak involved the largest reported num¬
ber of adult case patients in whom HUS developed and, ulti¬
mately, the largest number of deaths attributable to E. coli 0157:
H7 infection that has yet been recorded from 1 outbreak. Legal
proceedings delayed the collection and analysis of clinical data,
but we now report a retrospective analysis of predictors of HUS
and death among infected patients admitted to the hospital
during this outbreak.
SUBJECTS AND METHODS
Data collection. The Information Statistics Division of the
National Health Service in Scotland collated laboratory data on
all confirmed, probable, and possible cases of E. coli 0157:H7
infection identified in central Scotland during the outbreak
period. For all patients who were admitted to the hospital, data
were collected from case records with regard to premorbid
illness, regular medications, symptoms, signs, management, and
complications.
Inclusion criteria. The study included all patients with
"confirmed" and "probable" cases of E. coli 0157:H7 infection
who were admitted to the hospital during the outbreak of E.
coli 0157:H7 infection in central Scotland. Patients were con¬
sidered to have "confirmed" cases if the outbreak strain was
isolated from a stool sample by use of standard culture with
or without immunomagnetic separation [21]. Patients were
considered to have "probable" cases if they had bloody diarrhea
or HUS and an association with implicated food sources, but
no E. coli 0157:H7 or other organism was isolated from cul¬
tures. Lack of adequate recorded information precluded inclu¬
sion of case patients who were managed solely in the com¬
munity.
Outcome measures. "Complete HUS" was defined by the
following findings: evidence of red cell hemolysis (red cell frag¬
mentation on blood film and lactate dehydrogenase level [LDH]
>1.5 times the upper limit of normal), thrombocytopenia
(platelet countc 150 X 10'' cells/L), and acute renal impairment
(serum creatinine level >140 /xAF/L and rising), with or without
new neurological signs (acute confusion, reduced conscious¬
ness, seizure, cerebrovascular accident). One patient, who met
all other criteria, was included as having HUS despite a min¬
imum platelet count of 228 (on death).
Analysis. Demographic characteristics, clinical symptoms
and signs, antibiotic therapy, premorbid illness, regular med¬
ication, preadmission treatment, and laboratory variables were
assessed in relation to outcome measures (HUS and death) by
use of univariate and multivariate logistic regression analysis.
The dichotomization of continuous variables was achieved
either on the basis of examination of their distribution, which
yielded a natural cutoff value, or on the basis of examples of
categories used in previous studies. Because of limited sample
size, only variables found to be significantly associated with
outcome measures in the univariate analysis were included in
the multiple regression model.
Symptoms and signs were defined as those reported prior to
admission or <24 h after admission to the hospital. Fever was
defined as an axillary temperature >37.5°C that was recorded
=S24 h after admission. Antibiotic therapy was included if it
was initiated =S4 days after symptom onset. During the out¬
break, all case patients admitted to 1 hospital were asked spe¬
cifically about coincidental use of antibiotics (i.e. prescribed as
treatment for another infection <4 weeks before developing
symptoms related to E. coli 0157:H7 infection) and the use of
antimotility drugs. This information was not recorded at other
hospitals, and analysis is confined to patients who were ad¬
mitted to a hospital where the data were collected prospectively.
Chronic premorbid illness and regular medication were assessed
only for adults (>15 years of age), because no children had
premorbid illness or were taking regular medication.
This outbreak was unique in that laboratory data were mon¬
itored for all possible case patients from presentation until at
least day 14 of illness, in the hospital or in an outbreak-mon¬
itoring clinic. Levels ofWBCs, neutrophils, hemoglobin, serum
albumin, LDH, urea, and creatinine were assessed as predictors
of HUS on the basis of results for the first blood sample ob-
924 • CID 2001:33 (1 October) • Dundas et al.
Table 1. Demographic features, clinical signs and symptoms, and antibiotic therapy received for 120 patients
infected with Escherichia coli 0157:H7 who were hospitalized during the 1996 outbreak in central Scotland, with
results of logistic regression analyses showing the association between these factors and hemolytic uremic
syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) and death.
No. (%) of patients No. (%) of patients aged >65 years
Who had Adjusted OR
Factor Total HUS/TTP OR (95% CI) (95% CI) Total Who died OR (95% Cl)a
n 120 (100) 34 (28) — — 58 (100) 16 (28) —
Demographic data
Age, years
<15 24 (20) 8 (33) 3.61 (1.3-10.1)b 4.35 (1.3-14.4)b 0 0 —
15-65 38 (32) 5 (13) 1.00 (baseline) 1.00 (baseline) 0 0 —
>65 58 (48) 21 (34) 3.61 (1.3-10.1 )b 4.35 (1.3—14.4)b 58 (100) 16 (28) —
Sex
Male 41 (34) 12 (29) NS — 18 (31) 7 (39) NS
Female 79 (66) 22 (28) NS — 40 (69) 9 (23) NS
Signs and symptoms
Incubation <5 days0
Yes 46 (61) 16 (35) 3.47 (1.0-11.7) — 24 (65) 10 (42) NS
No 30 (39) 4 (13) 1.00 (baseline) — 13 (35) 1 (8) NS
Bloody diarrhea
Yes 105 (88) 31 (30) NS — 50 (86) 16 (32) NS
No 15 (12) 3 (20) 8 (14) 0
Abdominal pain
Yes 102 (85) 30 (29) NS — 48 (83) 13 (27) NS
No 18 (15) 4 (22) NS — 10 (17) 3 (30) NS
Fever
Yes 22 (18) 10 (45) 2.57 (1.0-6.7) 2.74 (1.0-7.6) 11 (19) 5 (45) NS
No 98 (82) 24 (24) 1.00 (baseline) 1.00 (baseline) 47 (81) 11 (23) NS
Vomiting
Yes 59 (49) 16 (25) NS — 21 (36) 4 (19) NS
No 61 (51) 18 (30) NS — 37 (64) 12 (32) NS
>10 stools/day
Yes 51 (43) 19 (37) NS — 24 (41) 7 (29) NS
No 69 (47) 15 (22) NS — 34 (59) 9 (26) NS
Light-headed
Yes 7 (6) 3 (43) NS — 6 (10) 4 (67) 6.67 (1.1-41.0)
No 113 (94) 31 (27) NS — 52 (90) 12 (23) 1.00 (baseline)
Abdominal tenderness11
Yes 68 (57) 19 (28) NS — 31 (58) 10 (32) NS
No 51 (43) 14 (28) NS — 27 (42) 6 (22) NS
Abdominal distention
Yes 10 (8) 4 (40) NS — 7 (12) 4 (57) NS
No 110 (92) 30 (27) NS — 51 (88) 12 (24) NS
Tachycardia11
Yes 8 (7) 6 (75) 9.33 (1.8-48.9) 7.91 (1.5-42.4) 3 (5) 1 (33) NS
No 111 (93) 27 (24) 1.00 (baseline) 1.00 (baseline) 55 (95) 15 (27) NS
Hypotension6
Yes 4 (3) 3 (75) NS — 3 (5) 1 (33) NS
No 112 (97) 30 (27) NS — 52 (95) 14 (27) NS
Dehydration01
Yes 16 (13) 7 (44) NS — 11 (19) 6 (55) 4.44 (1.1-17.6)
No 103 (87) 26 (25) NS — 47 (81) 10 (21) 1.00 (baseline)
Ciprofloxacin therapy 15 (13) 7 (47) NS - 11 (19) 5 (45) NS
NOTE. NS, P = .05.
8
Only 1 variable, dehydration, remained significant in the multiple regression, which, therefore, was not performed.
b
Patient groups aged <15 years and >65 years were combined in logistic regression analyses for HUS/TTR
c Data was missing for 44 patients; therefore, incubation period was not included in the multiple logistic regression analysis.
d Data was missing for 1 patient.
6
Data was missing for 4 patients.
Table 2. Premorbid illness and regular medication of adults infected with Escherichia coli 0157:H7 who were hospitalized
during the 1996 outbreak in central Scotland, with results of logistic regression analyses showing the association between
these factors and hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) and death.
Factor
Patients aged >15 years Patients aged >65 years
Total
Who had
HUS/TTP OR (95% CI)
Adjusted OR
(95% Cl)a Total Who died OR (95% Cl)b
n 95 (100) 25 (26) — — 58 (100) 16 (28) —
Premorbid illness
Ischemic heart disease
Yes 32 (34) 11 (34) NS — 28 (48) 9 (32) NS
No 63 (66) 14 (22) NS — 30 (52) 7 (23) NS
Hypertension
Yes 17 (18) 5 (29) NS — 15 (26) 1 (7) NS
No 78 (82) 20 (26) NS 43 (74) 15 (35) NS
Cardiac failure
Yes 5 (5) 1 (20) NS — 5 (9) 2 (40) NS
No 90 (95) 24 (27) NS — 53 (91) 14 (26) NS
Cerebrovascular disease
Yes 15 (16) 5 (33) NS — 12 (21) 4 (33) NS
No 80 (84) 20 (25) NS — 46 (79) 12 (26) NS
Diabetes mellitus
Yes 3 (3) 2 (67) NS — 1 (2) 0 NS
No 92 (97) 23 (25) NS — 57 (98) 16 (28) NS
Hypochlorhydria
Yes 15 (16) 9 (60) 6.00 (1.9-19.3) 6.73 (1.9-24.0) 10 (17) 6 (60) 5.70 (1.4-24.1)
No 80 (85) 16 (20) 1.00 (baseline) 1.00 (baseline) 48 (83) 10 (21) 1.00 (baseline)
Regular medication
Aspirin
Yes 18 (19) 6 (33) NS — 16 (28) 3 (19) NS
No 77 (81) 19 (25) NS — 42 (72) 13 (31) NS
ACE inhibitor
Yes 4 (4) 1 (25) NS — 4 (7) 1 (25) NS
No 91 (96) 24 (26) NS — 54 (93) 15 (28) NS
NO 11. ACE, angiotensin-converting enzyme; NS, P = .05.
a
Adjusted for age (i.e., the group 15-65 years of age vs. the group >65 years of age [see table 1]).
b
Only 1 variable, hypochlorhydria, was significantly associated with outcome of death; therefore, multiple regression analysis was not performed.
tained. Because of the potentially rapid development of HUS
(in 3 days, in 1 patient), only case patients from whom a first
blood sample was obtained =£48 h before the onset ofsymptoms
were included. This restriction limited the sample size; there¬
fore, multivariate analysis was not performed on this data. Fur¬
ther investigation of laboratory data (for the first 14 days of
illness), in all cases, was performed by examining the mean
value of variables per day after onset of symptoms in the group
of patients who had HUS develop and in the group who did
not. The t test for equality of means was applied to detect the
first day in which there was a significant difference in each
laboratory variable between the 2 groups.
RESULTS
In this study, 345 patients with confirmed and probable cases
of E. coli 0157:H7 infection were identified. Of those 345 pa¬
tients, 279 (81%) had their cases confirmed by stool culture
techniques; 120 case patients (35%) were admitted to 3 primary
hospitals. It is this third group that was investigated in the
regression analyses. The age range of case patients admitted to
the hospital was 18 months to 94 years, with a median age of
63 years. Patients were admitted occurred from 20 November
1996 through 16 December 1996.
Complications. Thirty-four case patients had HUS: 28
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Table 3. Preadmission treatment of 86 patients infected with Escherichia coli 0157:H7 who were hospitalized
during the 1996 outbreak in central Scotland, with results of logistic regression analyses showing the association
between these factors and hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) and death.
No. (%) of patients interviewed No. (%) of patients aged >65 years
Who had Adjusted OR
Treatment received Total HUS/TTP OR (95% CI) (95% Cl)a Total Who died OR (95% CI)
n 86 (100) 23 (27) — — 42 (100) 10 (24)
Antibiotic agents'5
Yes 14 (16) 8 (57) 5.07 (1.5-16.8) 4.71 (1.4-16.5) 10 (24) 4 (40) NS
No 72 (84) 15 (21) 1.00 (baseline) 1.00 (baseline) 32 (76) 6 (19) NS
Antidiarrheal agents
Yes 26 (31) 9 (35) NS — 16 (38) 3 (19) NS
No 60 (70) 14 (23) NS — 26 (62) 7 (27) NS
NOTE. NS, P = .05.
a
Adjusted for age (i.e., group 15-65 years of age vs. group <15 and >65 years of age (see table 1]).
b Received in the 4 weeks before the onset of symptoms.
adults and 6 children. HUS developed a median of 7 days
(range, 3-15 days) after the onset of gastrointestinal symptoms.
Twelve of 28 adults and 1 of 6 children had neurological com¬
plications of HUS, the most frequent of which was cerebro¬
vascular accident.
Deaths. Sixteen case patients (13%) who were admitted to
the hospital died; all were >65 years of age. Eleven had complete
HUS, 3 had an incomplete form of HUS, and 2 had no evidence
of microvascular complications. Seven of the 11 patients with
HUS who died had neurological complications. The mortality
rate among adults with HUS was 42% (11 of 26).
Treatment. The mainstay of treatment was supportive
with correction of fluid and electrolyte imbalance. Antibiotic
therapy for the treatment of gastroenteritis was prescribed
according to UK guidelines [22]; therefore, ciprofloxacin was
given to case patients >60 years of age who had preexisting
medical conditions or who were receiving immunosuppressive
therapy, acid-lowering drugs, or angiotensin-converting en¬
zyme (ACE) inhibitors [22], Twenty of 120 case patients re¬
ceived ciprofloxacin; no other antibiotic was given as primary
treatment. Therapeutic plasma exchange was performed for
16 adults [2] in 1 Health Board area and 1 adult from outside
that area. Five adults so treated had progressive renal im¬
pairment requiring hemodialysis. Seven children received
dialysis.
Predictors of HUS
Demographic details and clinical symptoms. Childhood and
old age were significantly associated with development of HUS
(figure 1). HUS developed in 29 (35%) of 82 case patients <15
years or >65 years of age, compared to 5 (13%) of 38 case
patients 15-65 years of age (adjusted OR, 4.4; 95% CI, 1.3-14.4;
table 1). Fever (adjusted OR, 2.7; 95% CI, 1.0-7.6) and tachy¬
cardia at admission (>100 beats/min for adults and >120 beats/
min for children; adjusted OR, 7.9; 95% CI, 1.5-42.4) were
associated with progression to HUS. No other gastrointestinal
or systemic features predicted development of HUS.
Premorbid medications and chronic illness. HUS devel¬
oped in 9 (60%) of 15 adults who had low levels of gastric acid
(either because they had previously undergone gastrectomy, or
because they were receiving proton pump inhibitors and/or H,-
receptor antagonists; adjusted OR, 6.7; 95% CI, 1.9-24.0; table
2).
Antibiotics. HUS developed in 8 (57%) of 14 case patients
who had received any antibiotic in the 4 weeks prior to the
onset of symptoms related to E. coli 0157:H7 infection (ad¬
justed OR, 4.7; 95% CI, 1.4-16.5; table 3). HUS developed in
7 (47%) of 15 case patients who were treated with ciprofloxacin
=£4 days after symptom onset and in 26 (25%) of 104 case
patients who had no antibiotic treatment, but this difference
did not reach statistical significance, (OR, 2.63; CI 0.76-9.02;
table 1).
Laboratory investigations. In a univariate analysis, WBC
count >20 X 10'' cells/L (OR, 8.3; 95% CI, 1.1-60.3) and an
absolute neutrophil count >15 X 109 cells/L (OR, 8.5; 95% CI,
1.5-50.1) =£48 h after symptom onset were both significantly
associated with the development of HUS. Serum albumin level
<35 g/L «48 h after symptom onset was also associated with
the development of HUS (OR, 7.2; 95% CI, 1.2-42.5; table 4).
Sequential analysis of laboratory results for the first 14 days of
illness for all 120 patients admitted to the hospital included
901 samples (figure 2). This analysis confirmed that neutro¬
philia and hypoalbuminemia precede the changes in the results
of laboratory tests that are regarded as indicating the devel¬
opment of HUS. There were significant differences in mean
neutrophil count on day 2 of clinical illness between patients
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Table 4. Laboratory test results obtained «48 h after onset of symptoms, with results of univariate logistic
regression analyses showing the association between these factors and hemolytic uremic syndrome/thrombotic
thrombocytopenic purpura (HUS/TTP) and death.
No. (%) of patients No. (%) of patients aged >65 years
Test result Total
Who had
HUS/TTP OR (95% CI) Total Who died OR (95% CI)
n 44 (100) 9 (20) 22 (100) 6 (27)
Neutrophil count >15 x 109 cells/L
Yes 7 (16) 4 (57) 8.53 (1.5-50.1) 6 (27) 3 (50) NS
No 37 (84) 5 (14) 1.00 (baseline) 16 (73) 3 (19) NS
WBC count >20 x 109 cells/L
Yes 5 (11) 3 (60) 8.25 (1.1-60.3) 5 (23) 3 (60) NS
No 39 (89) 6 (15) 1.00 (baseline) 17 (77) 3 (18) NS
Albumin level <35 g/L a
Yes 9 (23) 4 (44) 7.20 (1.2-42.5) 9 (47) 4 (44) NS
No 30 (77) 3 (10) 1.00 (baseline) 10 (53) 2 (20) NS
Creatinine level >120 nMIL
Yes 6 (14) 3 (50) NS 6 (27) 2 (33) NS
No 38 (86) 6 (16) NS 16 (73) 4 (25) NS
Urea concentration >10 pM/L
Yes 8 (18) 3 (38) NS 8 (36) 1 (13) NS
No 36 (82) 6 (17) NS 14 (64) 5 (36) NS
LDH level >600 U/Lb
Yes 1 (3) 0 NS 1 (6) 0 NS
No 36 (97) 7 (19) NS 16 (94) 6 (38) NS
Platelet count <200 x 109 cells/L
Yes 12 (27) 3 (25) NS 10 (45) 2 (20) NS
No 32 (73) 6 (19) NS 12 (55) 4 (33) NS
Hemoglobin level <12 g/L
Yes 2 (5) 1 (50) NS 2 (9) 1 (50) NS
No 42 (95) 8 (19) NS 20 (91) 5 (25) NS
Sodium
Yes 4 (9) 2 (50) NS 4 (18) 2 (50) NS
No 40 (90) 7 (13) NS 18 (82) 4 (22) NS
NOTE. LDH, lactate dehydrogenase; NS, P= .05.
a
Data were missing for 5 patients.
b Data were missing for 7 patients.
who had HUS develop and those who did not. The traditional
markers of HUS development (levels of LDH, urea, creatinine,
and platelet count) became significantly different in the 2
groups 4-6 days after the onset of diarrheal symptoms. The
sensitivity of a neutrophil count >15 X 109 cells/L as a predictor
of HUS was 94%, and the specificity was 78%.
Predictors of Death
All deaths occurred in patients aged >65 years, so analysis in
relation to this outcome was confined to this age group. Eleven
(69%) of 16 case patients who died had complete HUS, and 3
of 16 had thrombotic microangiopathy. Dehydration and feel¬
ing light-headed on admission were the only additional prog¬
nostic variables associated with death (table 1).
DISCUSSION
E. coli 0157:H7-induced HUS is associated with significant
mortality, particularly among elderly patients. There is evidence
that, by the time a diagnosis of HUS is made, the pathological
process is well established and difficult to reverse. Because there
are now promising therapies to prevent and treat HUS [1, 2],
the early identification of factors that predispose to HUS or
predict its development is essential.
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Figure 2. Mean results of laboratory tests on the day of onset of illness for patients infected with Escherichia coli 0157:H7 who developed
hemolytic uremic syndrome (HUS) and for those who did not.
This study included the largest number of adult patients with
HUS and the largest number of deaths associated with E. coli
0157:H7 infection to date. We found age <15 or >65 years to
be the most important predictor for development ofHUS. Early
neutrophilia also consistently predicted the development of
HUS and often preceded changes in other laboratory markers
by several days. This finding reinforces speculation that neu¬
trophils are pivotal in the pathogenesis of endothelial injury,
speculation that has been validated by the recent discovery that
neutrophils transport Shiga toxin [23]. Hypoalbuminemia also
preceded and predicted HUS. The association of hypoalbu¬
minemia and HUS may be a manifestation of severe gastro¬
intestinal infection or capillary leak secondary to endothelial
injury, but it may also reflect the fall in albumin seen in older
people, in whom it is a well-recognized indicator of poor prog¬
nosis [24],
Observations from the earliest outbreaks and a controlled
clinical trial failed to clarify the role of antibiotics in the de¬
velopment of HUS [5, 6, 11-13]. Retrospective analyses of the
massive 1996 Sakai City outbreak in Japan contributed to this
conflict: children treated early with fosfomycin had a reduced
incidence of HUS [14, 15]. A prospective clinical trial involving
children in the United States has demonstrated a clear asso¬
ciation between use of sulpha-containing and (3-lactam anti¬
biotics and increased risk of HUS [18], In vitro evidence has
shown that treatment with 4-quinolones increases the release
of Shiga toxin [16] and that this effect is mediated by phage
replication [25]. We were, however, unable to demonstrate a
significant association between early treatment with ciproflox¬
acin and HUS. Only a small number of selected case patients
received early antibiotic therapy. We did demonstrate an as¬
sociation between antibiotic use that precedes the onset of
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symptoms associated with E. coli 0157:H7 infection and the
development of HUS. This association has not been noted pre¬
viously and may be a clinical manifestation of the effect of
subtherapeutic concentrations of antibiotics. In vitro experi¬
ments have shown that subtherapeutic concentrations of an¬
tibiotics or treatment with inappropriate antibiotics increases
the release of Shiga toxin [26]. It now seems likely that the
effect of antibiotics on Shiga toxin production depends both
on their mechanism of action and on the achievement of ther¬
apeutic concentrations. Our observations regarding treatment
with ciprofloxacin and/or coincidental antibiotics advocate
against the use of antibiotic therapy for E. coli 0157:H7 in¬
fection.
The association of prior gastrectomy/acid-lowering drugs
with progression from gastrointestinal infection with E. coli
0157:H7 to HUS has not been noted previously. Patients have
been shown to be at increased susceptibility to other types of
bacterial gastroenteritis after gastrectomy [27], and 1 outbreak
suggested that previous gastrectomy was associated with ac¬
quiring E. coli 0157:H7 infection [5]. E. coli 0157:H7 is an
acid-tolerant organism, and hypochlorhydria was not thought
to be relevant in its pathogenesis; however, there is now evi¬
dence of a wide range of acid tolerance among different isolates
of E. coli 0157:H7 [28], An organism with reduced acid tol¬
erance could explain our observation of more severe illness in
case patients with reduced levels of gastric acid. Fever on ad¬
mission was found to be associated with HUS, as it was in the
1996 outbreak in Japan [17, 20].
We have presented a detailed retrospective study ofpredictors
of HUS and death in an outbreak of E. coli 0157:H7 infection
that had the largest number of deaths recorded to date. The
methods of the study ensure that no cases were overlooked,
that laboratory results and the collection of clinical data were
both accurate and complete. This was, however, a retrospective
study and as such may be limited by the accuracy and com
pleteness of the medical records kept during the outbreak
period.
This study has shown that mortality associated with HUS in
adults remains high even with intensive management. We con¬
firmed that age was the most important risk factor for HUS
and that neutrophilia as an early predictor extended to the adult
population. In addition, we identified low gastric acid and an¬
tibiotics prior to acquiring infection as risk factors. Patients
can be identified who require close supervision and could po¬
tentially be entered into trials of Shiga toxin-binding agents to
prevent HUS.
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ARTICLES
Effectiveness of therapeutic plasma exchange in the 1996
Lanarkshire Escherichia coli 0157:H7 outbreak
S Dundas, J Murphy, R L Soutar, G A Jones, S J Hutchinson, W T A Todd
Summary
Background The largest number of adult cases of
haemolytic uraemic syndrome (HUS)/thrombotic
thrombocytopenic purpura (TTP) during an Escherichia coli
0157 outbreak occurred in 1996 in central Scotland. Adults
who develop HUS/TTP induced by E coli 0157 tend to be
elderly and have a historical mortality rate of almost 90%
when treated conservatively. Therefore the decision was
made to treat adults who developed HUS/TTP during this
outbreak with therapeutic plasma exchange (TPE). We
report our outcome with this controversial treatment.
Methods A case definition for HUS/TTP was developed at
the beginning of the outbreak. All cases meeting this
definition were considered for TPE. Information on
demographics, clinical features, treatment and outcome of
patients was obtained by retrospective case note review.
Findings 22 adults developed HUS/TTP. They had a mean
age of 71 years. 16 cases received TPE. Six cases had
contraindications to TPE or died before the procedure could
be done. Ten of the 22 (45%) adults with HUS/TTP died.
Five of the 16 (31%) TPE-treated cases died, four of eight
aged over 70 years compared with one of eight aged less
than 70 years. Premorbid illness, neurological features,
treatment with ciprofloxacin or prostacyclin, and the
laboratory severity of HUS/TTP were not associated with
death; the number of cases, however, was too small to
allow statistical conclusion.
Interpretation The mortality rate is high in adults who
develop HUS/TTP induced by E coli 0157. TPE appears to
be a promising treatment that was well tolerated in our
elderly patients. A national register of adult cases of
HUS/TTP induced by E coli 0157 should be established.
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Introduction
Gastrointestinal infections with Escherichia coli 0157 are
an increasingly important public-health problem in the
UK. E coli 0157 was first recognised as a cause of
gastroenteritis in 1982/ and the number of cases is
increasing each year.2 For the past few years the rate of
infection by E coli 0157 in Scotland has been
consistently several times greater than that in the rest of
the UK, and Scotland now has one of the highest rates of
infection in the world.3 In the winter of 1996 central
Scotland experienced the worst outbreak, in terms of
mortality, of E coli 0157 infection ever recorded in the
western world.4
E coli 0157 infection has the potential for serious and
potentially life-threatening local5,6 and systemic
complications.7'8 The most severe systemic complications
are haemolytic uraemic syndrome (HUS)—a triad
of microangiopathic haemolysis, thrombocytopenia,
and acute renal impairment—and thrombotic
thrombocytopenic purpura (TTP)—microangiopathic
haemolysis and thrombocytopenia with neurological
symptoms and signs predominating over renal
impairment. In the context of E coli 0157 infection HUS
and TTP are overlapping syndromes. Thrombotic
microangiography—microangiopathic haemolysis and
thrombocytopenia in the absence of renal or neurological
disorders—is the earliest feature of the range of disease
that leads to HUS/TTP. All are a consequence of the
same pathological microvascular process mediated by the
E coli 0157 shiga toxins.' Risk factors associated with the
development of systemic complications have been
identified, the most consistent of which are extremes of
age (<4 years10,11 and >65 years'2,13) and raised white-
blood-cell count.14
A general consensus still supports the use of
therapeutic plasma exchange (TPE) in adults with
idiopathic HUS and in patients of all ages with TTP.15,16
This treatment is controversial for E coli 0157 infection,
since experience of TPE in the treatment of HUS/TTP
induced by this organism is limited. The outbreak in
central Scotland of E coli 0157 infection centred on the
Lanarkshire town of Wishaw where the implicated retail
outlets were located. The largest cohort within the
outbreak was a group of elderly people who attended a
Christmas church lunch. The elderly are known to be at
particular risk of developing HUS/TTP and the expected
mortality rate in those treated conservatively is 88%.13
We therefore decided early in the course of the
Lanarkshire outbreak to use TPE in the treatment of
adults who developed HUS/TTP.
Legal proceedings surrounding the 1996 outbreak
have delayed the compilation of clinical reports. We now
report the clinical outcomes with TPE in adults who
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Age distribution of Lanarkshire E coli 0157 cases
developed HUS/TTP in Lanarkshire during this
outbreak.
Patients and methods
The Information and Statistics Department of the Scottish
Home and Health Department collected data on the
demographics and laboratory results of all possible outbreak
cases. We collected clinical data by reviewing the case notes of
all cases admitted to hospital in the Lanarkshire area.
All confirmed or probable cases of E coli 0157 infection,
identified in the Lanarkshire area during the outbreak period,
were included in the assessment and analysis. Confirmed cases
were those in whom the outbreak strain of E coli 0157 was
isolated from stool samples. If stool cultures were negative at
the local laboratories, specimens were sent to Scotland's E coli
reference laboratory in Aberdeen, for the more sensitive
isolation method of immunomagnetic separation." Probable
cases were those with bloody diarrhoea or HUS/TTP, an
association with food sources implicated in the outbreak, no E
coli 0157 isolated, and no other organism isolated. Adults were
defined as patients 15 years of age or older.
To allow standardisation of diagnosis in the face of a huge
clinical workload, a case definition for HUS and TTP was
developed at the beginning of the outbreak. HUS was defined as
evidence of red-cell haemolysis (red-cell fragmentation on blood
film and lactate dehydrogenase >1-5 times the upper limit of
normal [our laboratory 0-480 IU/L]) plus thrombocytopenia
(platelets <150X10'/L) with rising urea and creatinine
concentrations. All three criteria had to be met before the
diagnosis could be made, but not necessarily on the same blood
sample. A diagnosis of TTP was given to patients who met
these laboratory criteria and developed new neurological
symptoms and signs. One patient was included as having
developed HUS despite a minimum platelet count of
228X lO'/L (on death). He had bloody diarrhoea, an association
with an implicated food source, acute renal failure, the criteria
for red-cell haemolysis, and a falling platelet count.
In the assessment of premorbid illness, medical histories
included as relevant were ischaemic heart disease, cardiac
failure, hypertension, cerebrovascular disease, renal disease,
diabetes, and immunosuppression. Pulmonary oedema was
diagnosed on clinical and radiological evidence.
TPE was performed at three centres with three Cobe Spectra
Apheresis Systems (Cobe Laboratories Ltd, Gloucester, UK)
and a Baxter Fenwal CS-3000 Plus Cell Separator (Baxter
Healthcare, Newberry, UK). Plasma was exchanged with
2-0-2-4 L fresh frozen plasma or cryosupernatant in refractory
patients.18 The anticoagulant used was ACD-A. A combination
of central and peripheral venous access was used. Intravenous
hydrocortisone was given with each exchange. Intravenous
prostacyclin was also given to cases receiving TPE, at doses
between 40 mg/h and 200 mg/h, where tolerated. Data were
analysed by means of SPSS (version 7.5).
Results
There were 262 cases of E coli 0157 infection in the
Lanarkshire area: 200 confirmed cases and 62 probable
cases. The median age of all affected was 53 years, but
there were higher numbers at the extremes of age
(figure). 47% (124/262) of infected individuals were over
55 years of age. 13 (5%) people died. In 10 cases death
was associated with the systemic complications of E coli
0157 infection.
28 (11%) of the Lanarkshire cases of E coli 0157 met
the diagnostic criteria for HUS/TTP. Cases met the
criteria for HUS/TTP a median of 7 days (range 4-15)
after the onset of gastrointestinal symptoms. A further
eight cases had evidence of thrombotic microangiopathy
but did not meet the criteria for HUS/TTP and were not


























1 40 F Yes Yes Yes Yes Yes Yes 11-9 242 31-1 150 1049 8-9
2 60 F Yes Yes Yes Yes Yes 11-2 215 24-6 64 1151 9-2
3 62 F Yes Yes Yes Yes 18-8 141 3-7 32 1028 10-5
4 63 F Yes Yes Yes 14-6 115 10-3 170 1065- 9-4
5 66 F Yes Yes 34-9 272 14-3 58 1812 10-3
6 69 M Yes Yes Yes 16-2 187 28-7 250 1043 11-2 Yes
7 69 M Yes Yes Yes Yes Yes 12-2 150 14-7 95 1052 16-0
8 70 M Yes Yes 18-9 105 9-2 145 555 12-7 Yes
9 70 F Yes Yes 13-2 162 23-0 83 939 10-0
10 70 M Yes Yes Yes Yes Yes 20-7 259 12-2 166 765 13-9 Yes
11 71 F Yes Yes Yes 13-7 114 6-9 166 1153 12-8
12 71 F Yes Yes Yes Yes Yes 8-6 139 22-4 85 1268 13-3
13 71 F Yes Yes 34-3 268 32-9 97 1410 11-2 Yes
14 72 F Yes Yes Yes Yes 20-2 177 21-8 29 1971 11-9 Yes
15 74 M Yes Yes Yes Yes Yes 23-4 196 8-7 115 1150 8-0
16 74 M Yes Yes Yes 15-0 219 4-9 86 1349 12-0 Yes
17 76 M Yes 33-7 116 14-2 148 676- 12-7 Yes
18 78 F Yes Yes Yes Yes 36-4 313 29-6 237 1112 12-1 Yes
19 79 F Yes Yes Yes 17-9 158 12-9 121 799 13-5 Yes
20 80 F Yes Yes 12-2 123 9-2 125 841 10-4
21 83 F Yes Yes Yes Yes 11-5 193 14-9 129 1729 11-2 Yes
22 90 F Yes Yes Yes Yes 32-6 269 12-5 121 903 14-1
Blood results taken from the day that criteria for HUS/TTP were reached, before TPE in cases so treated.
Table 1: Adult HUS/TTP cases
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Patient Reason
6 Cardiac arrest before transfer for plasma exchange
8 Diagnosis not suspected
13 Cardiac arrest before transfer for plasma exchange
17 Fluid overload, pneumonia, septicaemia
19 Acute abdomen, dementia, relatives' wish
22 Fluid overload, precarious fluid balance
Table 2: Reasons for patients not receiving TPE
adults and six (21%) were children. The median age of
adults who developed HUS/TTP was 71 years and the
median age of children 6 years. The demographics,
clinical features, treatment, laboratory results, and
outcome of the adult cases with HUS/TTP are shown in
table 1. Blood results are taken from the day that the
diagnostic criteria for HUS/TTP were met, before TPE
in cases so treated.
The mortality rate in adults with HUS/TTP was 45%
(ten of 22). Seven of 12 cases aged over 70 years and
three of ten aged 70 years or less died. There were no
deaths in children. Necropsies were done for all cases
who died. Causes of death in patients with HUS/TTP
were acute renal failure secondary to HUS (two cases),
cardiac arrest (two cases), intracerebral haemorrhage,
cerebral infarction, acute myocardial infarction, multiple
organ failure, hepatorenal syndrome secondary to
macronodular cirrhosis and septic shock.
TPE was used in 16 of the 22 adult patients with
HUS/TTP. For patients treated with TPE later received
haemodialysis, because of deteriorating renal function.
Patients who did not receive TPE were either too unwell
to tolerate the procedure or died before TPE could be
carried out (table 2).
In all 16 cases treated with TPE, the first exchange was
first done within 24 h of the criteria for HUS/TTP being
met. The minimum number of changes was one, the
maximum 16, and the median six. Patients underwent a
total of 107 procedures, and 1100 units of fresh frozen
plasma were used. Two patients proved refractory to
treatment with fresh frozen plasma, after five and six
exchanges, but were successfully treated by additional
TPE with cryosupernatant as the exchange fluid.
Five of the 16 (31%) TPE-treated patients died, four
of eight aged over 70 years and one of eight aged 70
years or less. Premorbid illness, neurological features,
treatment with ciprofloxacin or prostacyclin, and the
laboratory severity of HUS/TTP were not associated
with death, although the number of cases was too small
to allow statistical conclusion.
The most frequent complication associated with
plasma exchange was pulmonary oedema, which was
diagnosed on clinical and radiological grounds in 11
cases. Pulmonary oedema was not confined to patients
undergoing TPE; three of six HUS/TTP cases not
treated with TPE had pulmonary oedema.
Hypocalcaemia (calcium <2-12 mmol/L) occurred in 15
of the 16 patients treated with TPE. Although severe
(minimum serum calcium 1-32 mmol/L) in many cases,
intravenous calcium supplements were given when
appropriate and no clinical manifestations of
hypocalcaemia were observed. Hypomagnesaemia
(magnesium <0-7 mmol/L) occurred in eight patients;
intravenous magnesium was given as appropriate and no
clinical effects were observed. Other complications
associated with TPE were line infection with meticillin-
resistant Staphylococcus aureus and extravasation infusion.
Discussion
HUS/TTP used to be a rare disease in adults, with an
estimated frequency of one case per million per year." In
50% of cases it was associated with pregnancy,
malignant hypertension, HIV infection, cancer, or
chemotherapy, and the remainder of cases were familial
or of unknown cause. In 1986 the first association of
HUS/TPP with E coli 0157 infection was made7 and the
incidence of the disorder has since continued to rise in
parallel with the global rise in E coli 0157 infections.2
After exposure to E coli 0157, between 3% and 7% of all
patients progress to overt HUS/TTP.20 The incidence of
HUS/TTP is highest in children and elderly people.20
The course and prognosis of HUS/TTP differ
substantially between adults and children. Children with
HUS develop acute renal failure precipitately and the
treatment of choice is dialysis, which is initiated when
the child becomes oliguric. Most children respond to
dialysis, and mortality rates of less than 5% are now
reported.21 In the central Scotland outbreak there were
no deaths in children. Adults seem to develop
neurological or cardiovascular complications before the
onset of oliguria. Neurological features are associated
with increased mortality,22 and neurological and
cardiovascular complications of HUS/TTP were the
most frequent causes of death in the central Scotland
outbreak.
The only other reported experience of HUS/TTP
induced by E coli 0157 in adults of which we are aware
was from a Canadian nursing-home outbreak in 1985.13
In that outbreak 11 of 12 patients who developed
HUS/TTP died, compared with ten of 22 in the central
Scotland outbreak. The patients who developed
HUS/TTP in the nursing-home outbreak were slightly
older (mean age 83 years) and probably frailer than our
patients. All patients from the nursing-home outbreak
were admitted to hospital and treated with full
supportive therapy, but without TPE. We believe that
our use of TPE was the only difference in treatment
between our patients and those reported from the
Canadian nursing-home outbreak. Also, in our patients,
we can find no evidence of any other treatment
influencing outcome from HUS/TTP. We therefore
suggest that without the use of TPE the proportion of
HUS/TTP cases who died would have been higher.
When HUS/TTP develops secondary to
gastrointestinal infection with E coli 0157, endothelial
damage is mediated by the lysogenic-phage-encoded
shiga toxins 1 and 2.23 The shiga toxins enter the
systemic circulation causing microvascular damage at
target organs by a process that is thought to be mediated
by proinflammatory cytokines such as tumour necrosis
factor a and interleukins.24 Endothelial damage induces
the formation of large von Willebrand factor multimers,25
which in turn may cause platelet aggregation with the
formation of small-vessel thrombi in target organs. These
combined processes are manifest clinically as
thrombocytopenia, haemolytic anaemia, renal
impairment, and neurological features such as confusion,
seizures, and cerebrovascular accidents. The theoretical
basis for use of TPE in E coli 0157 infection is that it
may remove the shiga toxins, proinflammatory cytokines,
and von Willebrand factor multimers from the
circulation, thereby removing the factors that initiate and
perpetuate the microvascular process that leads to
HUS/TTP.
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Plasma exchange is an expensive (£2500 per person
treated in our hospital) and intensive procedure. Its
effectiveness in the treatment of HUS/TTP induced by
E coli 0157 needs to be shown definitively in a
multicentre, randomised controlled trial. However, for a
disease with very high mortality and just one potentially
beneficial treatment option, a trial that withholds this
option would be hard to justify. It would also be
extremely difficult to organise since cases of E coli 0157
occur sporadically. There will always be an unavoidable
selection bias within such a trial, with patients who are
excluded from treatment because they have
contraindications to TPE or who die before treatment
can be initiated.
If 5% of all cases of E coli 0157 develop HUS/TTP,
we would expect about 40 adult cases of HUS/TTP per
year in the UK (data from the Communicable Disease
Surveillance Centre and Scottish Centre for Infection
and Environmental Health). We suggest that a national
register be established for adult cases of HUS/TTP, as
currently operates for cases in children. This database
would enable monitoring of treatment and outcomes in
adults, providing definitive evidence of the effectiveness
of TPE within about 5 years.
There is no evidence from our experience that TPE is
harmful. A national register of HUS/TTP secondary to
E coli 0157 could define the role of TPE in the
treatment of this serious disorder.
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CONCISE COMMUNICATION
Blood Group and Susceptibility to Disease Caused by Escherichflti coli 0157
C. Caroline Blackwell,1 Stephanie Dundas,1 _ 1 Department, of Medical Microbiology and 2Medical Statistics Unit,
Valerie S. James,1 Doris A. C. Mackenzie,1 University of Edinburgh'; Edinburgh, and 3Infectious Diseases Unit,
Jan M. Braun,1 Abdulhamid M. Alkout,1 Monklands District General Hospital, Airdire, Scotland
W. T. Andrew Todd,3 Robert A. Elton,2
and Donald M. Weir1
Patients (n = 186) infected during the Escherichia coli 0157 outbreak in Scotland in 1996 were
assessed for blood group markers (ABO, Lewis, and P) associated with other gastrointestinal infec¬
tions. Binding ofbacteria to epithelial cells was assessed by flow cytometry. Buffy coats from blood
donors were examined for inflammatory responses to culture filtrates of the outbreak strain. Indi¬
viduals of blood group O comprised 63.4% of patients, compared with 53.4% (P < .05) and 53.9%
(P < .01) ofneighboring populations in Airdrie and Glasgow, respectively; group O also comprised
64.3% of patients with hemolytic uremic syndrome (HUS) and 87.5% of patients who died
(P < .05). No or weak agglutination by anti-P antiserum was observed for 40.7 % ofcontrol persons
(n = 122), 61.5% ofall patients (P = .0027), and 83.3% ofpatients with HUS (P = .013). The suscep¬
tibility of group O to E. coli was not associated with increased binding of bacteria to epithelial cells
or with higher production of tumor necrosis factor (TNF)-a or interleukin-6. Leukocytes of P-
negative blood donors produced higher levels of TNF-a than those of P-positive donors.
Morbidity and mortality associated with the outbreak of
Escherichia coli 0157 infection in central Scotland in 1996 raise
the question of why some individuals exposed to this organism
developed severe disease and others did not. Aside from the ex¬
tremes of age in those infected, few demographic factors have
been associated with susceptibility to this disease. In relation to
severity of disease, we have identified neutrophilia or hypo-
albuminemia in an individual at hospital admission as important
risk factors for hemolytic uremic syndrome (HUS) [1]. Identifi¬
cation of risk factors has clinical relevance, such as definition of
patients who require intensive monitoring and supportive treat¬
ment, and, controversially, definition of individuals in whom the
use of therapeutic plasma exchange (TPE) may prevent pro¬
gression to HUS [2].
Studies of other enteric pathogens indicate that blood group is
a risk factor for some of these diseases. Occurrence or severity of
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diarrheal disease due to E. coli [3], Vibrio cholerae, and Helico¬
bacterpylori is associated with 2 genetic characteristics: the O
blood group and the inability to secrete the water-soluble glyco¬
protein forms ofone's ABO blood group antigens (nonsecretion)
[4-6], The P blood group, characterized by a receptor on endo¬
thelial surfaces for the Shiga toxin (ST) [7], may be a third genetic
factor, but there have been conflicting reports on association be¬
tween P blood group and susceptibility to disease due to E. coli
0157 in white populations [8,9].
Our earlier work [4] demonstrated that H. pylori bound in high¬
er numbers to cells of individuals ofblood group O and that bind¬
ing of the bacteria was significantly associated with expression
of H type 2, the antigen of blood group O. In addition, individ¬
uals of blood group O produced significantly higher levels of
tumor necrosis factor (TNF)-a and interleukin (IL)-6 in re¬
sponse to H. pylori [10].
The aims of the study were as follows: (1) to assess ABO and
P blood groups and secretor status among patients with disease
due to E. coli 0157, in comparison with the population in central
Scotland; (2) to determine whether the H type 2 antigen is a re¬
ceptor for the outbreak strain or other strains of E. coli 0157;
and (3) to assess inflammatory responses to a culture filtrate of
the outbreak strain in relation to ABO and P blood groups.
* i
Subjects and Methods
Subjects. There were 186 patients in the study who developed
disease due to confirmed E. coli 0157 infection during the 1996 out¬
break in Lanarkshire. For each patient, 10 possible age- and sex-
matched control subjects were identified by computer selection
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from data generated from the Lanarkshire Community Health Index
(CHI), and, with their general practitioner's consent, they were invit¬
ed to participate. Of these, 122 agreed to participate and are included
as control subjects. Blood was drawn from patients at the time of
infection and was drawn from patients and control persons 1 year
after infection. Information on ABO but not Lewis or P blood groups
was available for 16 individuals who died in Lanarkshire hospitals,
12 in Monklands District General Hospital in Airdrie and 4 in Law
Hospital in Carluke. Results for patients and CHI control persons
were also compared with data obtained for earlier studies in central
Scotland [11,12].
Patients with clear evidence of red blood cell (RBC) hemolysis
were considered to have ST-mediated thrombotic microangiopathy
(TMA), a proportion ofwhom progressed to HUS. HUS was defined
by the following findings: RBC hemolysis (RBC fragmentation on
blood film and lactate dehydrogenase level > 1.5 times the upper
limit of normal); thrombocytopenia (platelet count < 150 X 109/L);
and acute renal impairment (serum creatinine level >140 /umol/L
and rising).
Determination ofblood groups. ABO blood group was deter¬
mined by slide agglutination with monoclonal anti-A and anti-B
reagents from the Scottish National Blood Transfusion Service
(SNBTS). Lewis antigens were determined by tube agglutination
with monoclonal anti-Lewisa and anti-Lewisb reagents (SNBTS).
Polyclonal anti-P typing serum (SNBTS) was used in slide aggluti¬
nations, with results recorded as follows: 3, strong; 2, moderate; 1,
weak; and 0, no visible agglutination. The cells also were incubated
with the anti-P serum for 30 min at room temperature, with aggluti¬
nation assessed by flow cytometry (Coulter) in comparison with
cells incubated for 30 min with PBS. Secretor status was assessed
by hemagglutination inhibition tests, and results were compared
with results for Lewis" and Lewisb antigens by ELISA for Lewis anti¬
gens in saliva.
Bacteria. In addition to the outbreak strain, 8 additional strains
of E. coli 0157 of different phage types were obtained from Dr.
M. F. Hanson (Central Microbiological Laboratory, Western Gen¬
eral Hospital, Edinburgh). The bacteria were cultured in category 3
high-containment facilities, and formalin-fixed cultures were used
in the binding assays.
Binding ofbacteria to epithelial cells. Binding of bacteria to
buccal epithelial cells of the different ABO blood groups and of the
Kato III gastric epithelial cell line was assessed by the flow cytometry
method described elsewhere [4]. Blood group antigens were detected
with monoclonal antibodies to H type 2, A, B, Lewis", and Lewisb by
flow cytometry. Bacterial binding was examined in relation to the
level of expression of blood group antigens, as reflected by the level
of monoclonal antibodies bound [4],
Screening for bacterial adhesins that bind blood group antigens.
The spectrophotometry method for detection of direct binding of
biotinylated synthetic blood group oligosaccharides (Syntesome)
was used [4]. Binding of fluorescein-labeled blood group oligo¬
saccharides to the bacteria was also examined by flow cytometry.
H. pylori strain NCTC 11637 [4], which expresses fucose-binding
adhesins, was included in each experiment as a positive control.
Inflammatory responses to E. coli 0157 antigens. Inflamma¬
tory responses elicited from leukocytes by a sterile culture filtrate of
E. coli 0157 were assessed by the blood group and P antigen level
of the donor. The bacteria were grown in nutrient broth for 24 h at
37 °C in universal containers. The baMtteria and filtrates were pre¬
pared in a category 3 high-containment facility. Buffy coats from
blood donors (n = 32) were obtained from the Blood Transfusion
Service, Royal Infirmary of Edinburgh. There were 8 donors each
of A, B, O, and AB blood groups, and the levels of IL-6 and TNF-a
were assessed by ELISA and bioassay, respectively [13],
Statistical analyses. Samples were coded so that the blood
groups were determined without reference to patient or control
group. Results were entered into a database and were assessed by
use of a statistical software package (Epi Info). Prevalence was com¬
pared between groups by x tests with Yates's correction, and con¬
fidence intervals (CIs) for odds ratios were calculated by exact
methods.
Results
Epidemiologicalstudy. AB O and P blood groups were deter¬
mined for 186 patients infected during the Lanarkshire outbreak
and for 122 control persons obtained through the CHI. Because the
proportion of blood group O among the CHI control persons was
higher than that among the population covered by the Lanark¬
shire Blood Transfusion Service based at Law Hospital (51%;
K. Liddle, personal communication), data for ABO blood groups
also were compared with data from our earlier study on an out¬
break of meningococcal disease at the Airdrie Academy [11]
and data for blood donors in greater Glasgow [12]. There was no
significant difference between the proportion of blood group O
among patients (63.4%) and that among the CHI group (58.3%);
however, compared with the larger groups, Airdrie (n = 371; 53.4%;
P < .05) and Glasgow (n = 5898; 53.9%; P < .01), there was a
significantly increased proportion of blood group O among the
patients. The proportion of patients with HUS who were blood
group O was 18 (64.3%) of28; however, among patients who died,
14 (87.5%) of 16 were blood group O, and this was significantly
increased, compared with all 3 control groups (P < .05; figure 1).
No differences in the proportions of secretors and nonsecretors
of ABO blood group antigens were observed between patient and
control groups.
RBC samples from 83 (61.5%) of 135 patients who attended
follow-up clinics were not agglutinated or were only weakly ag¬
glutinated by the anti-P antiserum, compared with 46 (40.7%) of
113 samples from the CHI control persons (P = .0017; 95% CI,
1.35-4.00). Among 17 patients who attended the follow-up clin¬
ics and who developed TMA, 14 (82.4%) had no or only weak
reactions to anti-P antiserum, compared with 46 (40.7%) of the
113 CHI control persons (P = .0032; 95% CI, 1.73-38.41).
Among patients with TMA, 12 developed HUS, and 10 (83.3%)
had no or only weak reactions to anti-P, compared with 46
(40.7%) of the 113 CHI control persons (P = .0130; 95% CI,
1.43-70.37). Data on P blood group were not available for
patients who died.
Bacterial binding in relation to blood group and secretor status.
Nine strains of E. coli 0157, including the outbreak strain, were
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Figure 1. Percentages of blood group O individuals in control and
patient groups. CHI, Community Health Index (Lanarkshire); HUS,
hemolytic uremic syndrome.
tested for binding to epithelial cells of secretor and nonsecretor
donors of blood groups A, B, O, and AB. There was no correla¬
tion between binding of the bacteria to the Kato III cell line or
epithelial cells from the donors and expression of ABO or Lewis
blood group antigens.
Binding of labeled blood group oligosaccharides to E. coli
0157. None of the strains bound any of the biotinylated or fluo-
rescein-labeled ABO or Lewis blood group antigens. However,
the oligosaccharides bound to the H. pylori control in the assays.
Inflammatory responses and blood group. No significant
differences in levels of either TNF-a or IL-6 were associated
with ABO blood group. With respect to P antigen effect on the
RBCs, there were no differences in IL-6 levels. There were 8 do¬
nors whose RBCs were not agglutinated by anti-P, and 5 of
these blood samples produced TNF-a levels >100 IU/mL in
response to the culture filtrate. None of the donor RBC samples
expressing P antigen produced TNF-a responses approaching
100 IU/mL (P = .001).
Discussion
Among patients infected by E. coli 0157 during the Lanark¬
shire outbreak, the proportion who were blood group O was
63.4%, which was significantly higher than that of the general
population in the surrounding area (51 %-53.3%) but not signifi¬
cantly higher than that of the internal control group of 122 indi¬
viduals selected from the CHI. The proportion of blood group O
individuals who died during the outbreak was significantly in¬
creased, compared with all 3 control groups. In contrast to our
earlier studies on H. pylori [4, 10], Ae increased susceptibility
of blood group O individuals to disease due to E. coli 0157 was
not associated with increased binding of bacteria to epithelial
cells of blood group O or to higher inflammatory responses of
blood group O leukocytes.
The high proportion of patients with disease due to E. coli
0157 (61.5%) whose erythrocytes were not agglutinated or only
weakly agglutinated by anti-P antiserum, particularly those who
developed TMA (82.4%) or HUS (83.3%), supports the findings
obtained for 32 children with HUS, among whom there was a sig¬
nificant excess of patients with weak or absent expression of PI,
particularly among those with poor disease outcome [8], Unfortu¬
nately, there is no information on the P blood group for patients
who died. Two possibilities are suggested. The P antigen on eryth¬
rocytes can absorb the ST and prevent it from reaching target cells
in the kidney or brain, or ST and/or endotoxin in the culture filtrate
is better able to bind to leukocytes of individuals who do not ex¬
press P antigen or have low levels of this antigen on their cells.
TNF-a has been implicated as a major factor in tissue damage
in an animal model of E. coli 0157 [14]. High levels of TNF-a,
IL-6, IL-8, IL-10, and IL-1 receptor antagonist have been report¬
ed among patients infected with E. coli 0157 [15]. The induction
of very high levels of TNF-a by the culture filtrate from leuko¬
cytes of P-negative individuals is an observation to be pursued.
The results of these studies complement findings of an increased
proportion of individuals with low levels of P antigen on their
RBCs in the patient group, particularly among the patients who
developed HUS. This observation might help identify individ¬
uals at greater risk of more-serious disease caused by E. coli
0157 and, in particular, those who would benefit from TPE [2],
This study identified 2 genetic risk factors for disease due to E.
coli 0157. Although the original hypothesis that individuals of
blood group O might be at increased risk ofdisease was supported
by the data, the variations in levels of the P blood group antigen
appear to be more important in relation to severity of disease.
These findings provide new avenues for investigation of the dif¬
ferences in host susceptibility factors and responses that contrib¬
ute to development of serious kidney and vascular damage in
response to these infections.
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